{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:08:47Z","timestamp":1794553727286,"version":"4.9.1"},"reference-count":343,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LMS26H090007"],"award-info":[{"award-number":["LMS26H090007"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ningbo Top Medical and Health Research Program","award":["2022020304"],"award-info":[{"award-number":["2022020304"]}]},{"name":"Ningbo Clinical Research Center for Emergency and Critical Diseases","award":["2024L003"],"award-info":[{"award-number":["2024L003"]}]},{"DOI":"10.13039\/100007834","name":"Ningbo Natural Science Foundation","doi-asserted-by":"crossref","award":["2023J019"],"award-info":[{"award-number":["2023J019"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ningbo Youth Science and Technology Innovation Leading Talent Project","award":["2025QL015"],"award-info":[{"award-number":["2025QL015"]}]},{"name":"Chronic Disease Management Research Project of National Health Commission Capacity Building and Continuing Education Center","award":["GWJJMB202510021112"],"award-info":[{"award-number":["GWJJMB202510021112"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Subarachnoid hemorrhage (SAH) is an extremely lethal cerebrovascular emergency that can lead to severe long term neurological deficits. Modern research evidence indicates that the incidence of SAH varies significantly across different regions and populations, and this variation is determined by the interaction between non\u2014modifiable factors (such as age, gender, family history, and genetic susceptibility) and modifiable factors (such as hypertension, smoking, drug use, and metabolic disorders). Advancements in vascular biology and genomics further suggest that extracellular matrix instability, endothelial dysfunction, chronic inflammation, and population\u2014specific genetic variations play crucial roles in aneurysm formation and rupture. After aneurysm rupture, SAH triggers a biphasic injury cascade. Early brain injury (EBI) occurs within minutes to hours, manifesting as a sudden increase in intracranial pressure, systemic hypoperfusion, blood brain barrier disruption, neuroinflammation, cerebral edema, and metabolic failure. These early disturbances create favorable conditions for delayed cerebral ischemia (DCI), which occurs several days later due to microvascular dysfunction, impaired neurovascular coupling, cortical spreading depolarization, and progressive immunometabolic changes. Understanding this mechanistic continuum is of great significance for early detection and selection of treatment targets. Recent advancements in neuroimaging, biomarker development, and multimodal monitoring have improved diagnostic accuracy, while current management measures include rapid aneurysm fixation, optimized intensive care, and emerging neuroprotective strategies. Despite these advancements, treatment outcomes remain suboptimal, highlighting the need for further improvements in risk stratification, mechanism-based interventions, and population specific preventive measures. This review synthesizes the latest knowledge on the epidemiology, risk factors, pathogenesis, and clinical management of SAH to support a more comprehensive research and care framework.<\/jats:p>","DOI":"10.1186\/s43556-026-00455-y","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T10:11:58Z","timestamp":1777284718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Subarachnoid hemorrhage: epidemiology, risk factors, pathogenesis, and clinical therapies"],"prefix":"10.1186","volume":"7","author":[{"given":"Hangyu","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3598-9747","authenticated-orcid":false,"given":"Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"455_CR1","doi-asserted-by":"publisher","unstructured":"Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459\u2013480. https:\/\/doi.org\/10.1016\/s1474-4422(18)30499-x.","DOI":"10.1016\/s1474-4422(18)30499-x"},{"key":"455_CR2","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.13.04160","volume":"13","author":"Y Huang","year":"2023","unstructured":"Huang Y, Li Y, Pan H, Han L. Global, regional, and national burden of neurological disorders in 204 countries and territories worldwide. J Glob Health. 2023;13:04160. https:\/\/doi.org\/10.7189\/jogh.13.04160.","journal-title":"J Glob Health"},{"issue":"7","key":"455_CR3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41582-019-0208-y","volume":"15","author":"R Kaji","year":"2019","unstructured":"Kaji R. Global burden of neurological diseases highlights stroke. Nat Rev Neurol. 2019;15(7):371\u20132. https:\/\/doi.org\/10.1038\/s41582-019-0208-y.","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"455_CR4","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1001\/jamaneurol.2019.0006","volume":"76","author":"N Etminan","year":"2019","unstructured":"Etminan N, Chang H-S, Hackenberg K, De Rooij NK, Vergouwen MDI, Rinkel GJE, et al. Worldwide Incidence of Aneurysmal Subarachnoid Hemorrhage According to Region, Time Period, Blood Pressure, and Smoking Prevalence in the Population: A Systematic Review and Meta-analysis. JAMA Neurol. 2019;76(5):588\u201397. https:\/\/doi.org\/10.1001\/jamaneurol.2019.0006.","journal-title":"JAMA Neurol"},{"issue":"4","key":"455_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/s1474-4422(09)70025-0","volume":"8","author":"VL Feigin","year":"2009","unstructured":"Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8(4):355\u201369. https:\/\/doi.org\/10.1016\/s1474-4422(09)70025-0.","journal-title":"Lancet Neurol"},{"issue":"4","key":"455_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/s1474-4422(09)70023-7","volume":"8","author":"SC Johnston","year":"2009","unstructured":"Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol. 2009;8(4):345\u201354. https:\/\/doi.org\/10.1016\/s1474-4422(09)70023-7.","journal-title":"Lancet Neurol"},{"issue":"4","key":"455_CR7","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/s1474-4422(09)70024-9","volume":"8","author":"M O'donnell","year":"2009","unstructured":"O\u2019donnell M, Yusuf S. Tackling the global burden of stroke: the need for large-scale international studies. Lancet Neurol. 2009;8(4):306\u20137. https:\/\/doi.org\/10.1016\/s1474-4422(09)70024-9.","journal-title":"Lancet Neurol"},{"issue":"4","key":"455_CR8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1179\/016164106x115008","volume":"28","author":"RP Ostrowski","year":"2006","unstructured":"Ostrowski RP, Colohan AR, Zhang JH. Molecular mechanisms of early brain injury after subarachnoid hemorrhage. Neurol Res. 2006;28(4):399\u2013414. https:\/\/doi.org\/10.1179\/016164106x115008.","journal-title":"Neurol Res"},{"issue":"2","key":"455_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1161\/01.str.23.2.205","volume":"23","author":"EC Haley","year":"1992","unstructured":"Haley EC, Kassell NF, Torner JC. The International Cooperative Study on the Timing of Aneurysm Surgery. The North American experience. Stroke. 1992;23(2):205\u201314. https:\/\/doi.org\/10.1161\/01.str.23.2.205.","journal-title":"Stroke"},{"issue":"1","key":"455_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrneurol.2013.246","volume":"10","author":"RL Macdonald","year":"2014","unstructured":"Macdonald RL. Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol. 2014;10(1):44\u201358. https:\/\/doi.org\/10.1038\/nrneurol.2013.246.","journal-title":"Nat Rev Neurol"},{"key":"455_CR11","doi-asserted-by":"publisher","unstructured":"Diringer MN, Bleck TP, Claude Hemphill J, 3rd, Menon D, Shutter L, Vespa P, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211\u201340. https:\/\/doi.org\/10.1007\/s12028-011-9605-9.","DOI":"10.1007\/s12028-011-9605-9"},{"issue":"5","key":"455_CR12","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1212\/con.0000000000001052","volume":"27","author":"SH Chou","year":"2021","unstructured":"Chou SH. Subarachnoid hemorrhage. Continuum (Minneap Minn). 2021;27(5):1201\u201345. https:\/\/doi.org\/10.1212\/con.0000000000001052.","journal-title":"Continuum (Minneap Minn)"},{"issue":"1","key":"455_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-11894-y","volume":"15","author":"Y Wei","year":"2025","unstructured":"Wei Y, Lin X, Lin M, Li W, Luo H, Zhu G. Constructing a nomogram for short-term prognosis in postoperative patients with aneurysmal subarachnoid hemorrhage: a two-center retrospective study. Sci Rep. 2025;15(1):28153. https:\/\/doi.org\/10.1038\/s41598-025-11894-y.","journal-title":"Sci Rep"},{"issue":"3","key":"455_CR14","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3171\/2025.2.Jns242210","volume":"143","author":"M Renaudier","year":"2025","unstructured":"Renaudier M, Degos V, Pisanu G, Granger B, Abdennour L, Tabillon C, et al. Predicting patients with poor functional outcome after spontaneous aneurysmal subarachnoid hemorrhage: the predicting subarachnoid hemorrhage long-term outcome score. J Neurosurg. 2025;143(3):615\u201323. https:\/\/doi.org\/10.3171\/2025.2.Jns242210.","journal-title":"J Neurosurg"},{"key":"455_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1536643","volume":"16","author":"D Culebras","year":"2025","unstructured":"Culebras D, Pedrosa L, Mosteiro A, Llull L, Topczewski T, Zattera L, et al. Prognostic factors in aneurysmal subarachnoid hemorrhage with poor initial clinical grade. Front Neurol. 2025;16:1536643. https:\/\/doi.org\/10.3389\/fneur.2025.1536643.","journal-title":"Front Neurol"},{"issue":"1","key":"455_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s44337-025-00302-z","volume":"2","author":"S Thilak","year":"2025","unstructured":"Thilak S, Brown P, Lawrence E, Gopal S, Mullhi R, Chacko C, et al. Delayed cerebral ischaemia after subarachnoid haemorrhage: pathophysiology, diagnosis and neurotherapeutic opportunities. Discover Med. 2025;2(1):103. https:\/\/doi.org\/10.1007\/s44337-025-00302-z.","journal-title":"Discover Med"},{"issue":"1","key":"455_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3171\/jns.1968.28.1.0014","volume":"28","author":"WE Hunt","year":"1968","unstructured":"Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28(1):14\u201320. https:\/\/doi.org\/10.3171\/jns.1968.28.1.0014.","journal-title":"J Neurosurg"},{"issue":"3","key":"455_CR18","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1161\/strokeaha.123.044790","volume":"55","author":"AM Mistry","year":"2024","unstructured":"Mistry AM, Saver J, Mack W, Kamel H, Elm J, Beall J. Subarachnoid Hemorrhage Trials: Cutting, Sliding, or Keeping mRS Scores and WFNS Grades. Stroke. 2024;55(3):779\u201384. https:\/\/doi.org\/10.1161\/strokeaha.123.044790.","journal-title":"Stroke"},{"issue":"2","key":"455_CR19","doi-asserted-by":"publisher","first-page":"244","DOI":"10.4103\/1673-5374.346542","volume":"18","author":"Q Tian","year":"2023","unstructured":"Tian Q, Liu S, Han S-M, Zhang W, Qin X-Y, Chen J-H, et al. The mechanism and relevant mediators associated with neuronal apoptosis and potential therapeutic targets in subarachnoid hemorrhage. Neural Regen Res. 2023;18(2):244\u201352. https:\/\/doi.org\/10.4103\/1673-5374.346542.","journal-title":"Neural Regen Res"},{"key":"455_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jocn.2017.02.001","volume":"42","author":"VZ Zheng","year":"2017","unstructured":"Zheng VZ, Wong GKC. Neuroinflammation responses after subarachnoid hemorrhage: a review. J Clin Neurosci. 2017;42:7\u201311. https:\/\/doi.org\/10.1016\/j.jocn.2017.02.001.","journal-title":"J Clin Neurosci"},{"key":"455_CR21","doi-asserted-by":"publisher","unstructured":"Lin R, Guan S, Wang J, Han M, Fan M, Wan J, et al. Mechanisms and interventions in aneurysmal subarachnoid hemorrhage: Unraveling the role of inflammatory responses and cell death in early brain injury (Review). Mol Med Rep. 2025;32(3). https:\/\/doi.org\/10.3892\/mmr.2025.13621.","DOI":"10.3892\/mmr.2025.13621"},{"key":"455_CR22","doi-asserted-by":"publisher","unstructured":"Suzuki H, Kawakita F, Asada R. Neuroelectric Mechanisms of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage. Int J Mol Sci. 2022;23(6). https:\/\/doi.org\/10.3390\/ijms23063102.","DOI":"10.3390\/ijms23063102"},{"issue":"12","key":"455_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-017-0690-x","volume":"19","author":"JR Geraghty","year":"2017","unstructured":"Geraghty JR, Testai FD. Delayed cerebral ischemia after subarachnoid hemorrhage: beyond vasospasm and towards a multifactorial pathophysiology. Curr Atheroscler Rep. 2017;19(12):50. https:\/\/doi.org\/10.1007\/s11883-017-0690-x.","journal-title":"Curr Atheroscler Rep"},{"issue":"1","key":"455_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s12028-023-01738-w","volume":"39","author":"S Deem","year":"2023","unstructured":"Deem S, Diringer M, Livesay S, Treggiari MM. Hemodynamic management in the prevention and treatment of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2023;39(1):81\u201390. https:\/\/doi.org\/10.1007\/s12028-023-01738-w.","journal-title":"Neurocrit Care"},{"issue":"7620","key":"455_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nature19949","volume":"537","author":"R Aebersold","year":"2016","unstructured":"Aebersold R, Mann M. Mass-spectrometric exploration of proteome structure and function. Nature. 2016;537(7620):347\u201355. https:\/\/doi.org\/10.1038\/nature19949.","journal-title":"Nature"},{"issue":"3","key":"455_CR26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJMcp1605827","volume":"377","author":"MT Lawton","year":"2017","unstructured":"Lawton MT, Vates GE. Subarachnoid hemorrhage. N Engl J Med. 2017;377(3):257\u201366. https:\/\/doi.org\/10.1056\/NEJMcp1605827.","journal-title":"N Engl J Med"},{"issue":"11","key":"455_CR27","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1080\/14737175.2016.1203257","volume":"16","author":"C Burrell","year":"2016","unstructured":"Burrell C, Avalon NE, Siegel J, Pizzi M, Dutta T, Charlesworth MC, et al. Precision medicine of aneurysmal subarachnoid hemorrhage, vasospasm and delayed cerebral ischemia. Expert Rev Neurother. 2016;16(11):1251\u201362. https:\/\/doi.org\/10.1080\/14737175.2016.1203257.","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"455_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s12031-024-02194-7","volume":"74","author":"V Narayan","year":"2024","unstructured":"Narayan V, Kumar M, Mahajan S, Ganesh V, Luthra A, Gupta T, et al. The Role of Serum Matrix Metalloproteinase-9 as a Predictor of Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage. J Mol Neurosci. 2024;74(1):18. https:\/\/doi.org\/10.1007\/s12031-024-02194-7.","journal-title":"J Mol Neurosci"},{"issue":"3","key":"455_CR29","doi-asserted-by":"publisher","first-page":"174","DOI":"10.4103\/hm.HM-D-24-00163","volume":"9","author":"X Liu","year":"2025","unstructured":"Liu X, Zhang T, Yang L, Chen G, Ding P, Yu D, et al. National Institute of Health Stroke Scale Score mediated the relationship between systemic inflammatory response index, high-sensitivity C-reactive protein, and functional prognosis of acute ischemic stroke: a prospective cross-sectional study. Heart Mind. 2025;9(3):174\u201384. https:\/\/doi.org\/10.4103\/hm.HM-D-24-00163.","journal-title":"Heart Mind"},{"issue":"3","key":"455_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263460","volume":"17","author":"P Vlachogiannis","year":"2022","unstructured":"Vlachogiannis P, Hillered L, Enblad P, Ronne-Engstr\u00f6m E. Temporal patterns of inflammation-related proteins measured in the cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage using multiplex proximity extension assay technology. PLoS ONE. 2022;17(3):e0263460. https:\/\/doi.org\/10.1371\/journal.pone.0263460.","journal-title":"PLoS ONE"},{"issue":"9","key":"455_CR31","doi-asserted-by":"publisher","first-page":"4284","DOI":"10.1021\/acs.jproteome.1c00238","volume":"20","author":"KC Cho","year":"2021","unstructured":"Cho KC, Oh S, Wang Y, Rosenthal LS, Na CH, Zhang H. Evaluation of the sensitivity and reproducibility of targeted proteomic analysis using data-independent acquisition for serum and cerebrospinal fluid proteins. J Proteome Res. 2021;20(9):4284\u201391. https:\/\/doi.org\/10.1021\/acs.jproteome.1c00238.","journal-title":"J Proteome Res"},{"issue":"7","key":"455_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2023.100577","volume":"22","author":"JM Bader","year":"2023","unstructured":"Bader JM, Albrecht V, Mann M. MS-based proteomics of body fluids: the end of the beginning. Mol Cell Proteomics. 2023;22(7):100577. https:\/\/doi.org\/10.1016\/j.mcpro.2023.100577.","journal-title":"Mol Cell Proteomics"},{"key":"455_CR33","doi-asserted-by":"publisher","unstructured":"Rautalin I, Volovici V, Stark BA, Johnson CO, Kaprio J, Korja M, et al. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021. JAMA Neurol. 2025. https:\/\/doi.org\/10.1001\/jamaneurol.2025.1522.","DOI":"10.1001\/jamaneurol.2025.1522"},{"issue":"5","key":"455_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0323453","volume":"20","author":"W Li","year":"2025","unstructured":"Li W, Yang H, Rui F, Ruan X, Xiong J, Chen L. Systematic analysis of the global, regional, and national burden of subarachnoid hemorrhage from 1990 to 2021. PLoS ONE. 2025;20(5):e0323453. https:\/\/doi.org\/10.1371\/journal.pone.0323453.","journal-title":"PLoS ONE"},{"issue":"1","key":"455_CR35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40779-024-00551-6","volume":"11","author":"B Lv","year":"2024","unstructured":"Lv B, Lan J-X, Si Y-F, Ren Y-F, Li M-Y, Guo F-F, et al. Epidemiological trends of subarachnoid hemorrhage at global, regional, and national level: a trend analysis study from 1990 to 2021. Mil Med Res. 2024;11(1):46. https:\/\/doi.org\/10.1186\/s40779-024-00551-6.","journal-title":"Mil Med Res"},{"issue":"29","key":"455_CR36","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2025.40.e171","volume":"40","author":"J Park","year":"2025","unstructured":"Park J, Baek JY, Lee SH, Jung KH, Lee HY, Shin A, et al. Trends in Incidences, Treatments and Outcomes of Spontaneous Subarachnoid Hemorrhage in Korea Between 2002 and 2022. J Korean Med Sci. 2025;40(29):e171. https:\/\/doi.org\/10.3346\/jkms.2025.40.e171.","journal-title":"J Korean Med Sci"},{"key":"455_CR37","doi-asserted-by":"publisher","unstructured":"Cheng Z, Wang L, Wang X, Xuan J, Xu B, You L. Analysis and comparison of trends in the burden of subarachnoid hemorrhage in china and globally, 1990&#x2013;2021. J Stroke Cerebrovasc Dis. 2025;34(6). https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2025.108303.","DOI":"10.1016\/j.jstrokecerebrovasdis.2025.108303"},{"issue":"1","key":"455_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-024-03659-3","volume":"24","author":"Y Han","year":"2024","unstructured":"Han Y, Zhang B, Qi X, Yuan G, Li X, Hao G, et al. Comparison of sex differences on outcomes after aneurysmal subarachnoid hemorrhage: a propensity score-matched analysis. BMC Neurol. 2024;24(1):153. https:\/\/doi.org\/10.1186\/s12883-024-03659-3.","journal-title":"BMC Neurol"},{"key":"455_CR39","doi-asserted-by":"publisher","unstructured":"Chen G, Cai Y, Ju M, Zheng X, Bai P. Insights into the epidemiological analysis of subarachnoid hemorrhage burden and trends in middle-aged and elderly populations: a global perspective from the Global Burden of Disease Study 2021. Front Neurol. 2025;(16). https:\/\/doi.org\/10.3389\/fneur.2025.1518319.","DOI":"10.3389\/fneur.2025.1518319"},{"key":"455_CR40","doi-asserted-by":"publisher","unstructured":"Chen P, Chen J, Liu J. Rising burden of subarachnoid hemorrhage linked to high systolic blood pressure among young and middle-aged populations: temporal trends and global implication. Front Hum Neurosci. 2025;(19). https:\/\/doi.org\/10.3389\/fnhum.2025.1700918.","DOI":"10.3389\/fnhum.2025.1700918"},{"key":"455_CR41","doi-asserted-by":"publisher","unstructured":"Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795\u2013820. https:\/\/doi.org\/10.1016\/s1474-4422(21)00252-0.","DOI":"10.1016\/s1474-4422(21)00252-0"},{"issue":"8","key":"455_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14894","volume":"30","author":"P Xu","year":"2024","unstructured":"Xu P, Liu Y, Wang J, Zhang A, Wang K, Wang Z, et al. Gender-specific prognosis models reveal differences in subarachnoid hemorrhage patients between sexes. CNS Neurosci Ther. 2024;30(8):e14894. https:\/\/doi.org\/10.1111\/cns.14894.","journal-title":"CNS Neurosci Ther"},{"issue":"12","key":"455_CR43","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/s41588-020-00725-7","volume":"52","author":"MK Bakker","year":"2020","unstructured":"Bakker MK, Van Der Spek RAA, Van Rheenen W, Morel S, Bourcier R, Hostettler IC, et al. Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors. Nat Genet. 2020;52(12):1303\u201313. https:\/\/doi.org\/10.1038\/s41588-020-00725-7.","journal-title":"Nat Genet"},{"key":"455_CR44","doi-asserted-by":"publisher","first-page":"e823","DOI":"10.1016\/j.wneu.2017.11.108","volume":"110","author":"EP Hong","year":"2018","unstructured":"Hong EP, Kim BJ, Kim C, Choi HJ, Jeon JP. Association of SOX17 gene polymorphisms and intracranial aneurysm: a case-control study and meta-analysis. World Neurosurg. 2018;110:e823\u20139. https:\/\/doi.org\/10.1016\/j.wneu.2017.11.108.","journal-title":"World Neurosurg"},{"issue":"7","key":"455_CR45","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3349\/ymj.2019.60.7.651","volume":"60","author":"B Li","year":"2019","unstructured":"Li B, Hu C, Liu J, Liao X, Xun J, Xiao M, et al. Associations among Genetic Variants and Intracranial Aneurysm in a Chinese Population. Yonsei Med J. 2019;60(7):651\u20138. https:\/\/doi.org\/10.3349\/ymj.2019.60.7.651.","journal-title":"Yonsei Med J"},{"issue":"1","key":"455_CR46","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00701-020-04536-x","volume":"163","author":"A Hosmann","year":"2021","unstructured":"Hosmann A, Milivojev N, Dumitrescu S, Reinprecht A, Weidinger A, Kozlov AV. Cerebral nitric oxide and mitochondrial function in patients suffering aneurysmal subarachnoid hemorrhage-a translational approach. Acta Neurochir (Wien). 2021;163(1):139\u201349. https:\/\/doi.org\/10.1007\/s00701-020-04536-x.","journal-title":"Acta Neurochir (Wien)"},{"issue":"1","key":"455_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00504","volume":"22","author":"BSK Yang","year":"2025","unstructured":"Yang BSK, Blackburn SL, Lorenzi PL, Choi HA, Gusdon AM. Metabolomic and lipidomic pathways in aneurysmal subarachnoid hemorrhage. Neurotherapeutics. 2025;22(1):e00504. https:\/\/doi.org\/10.1016\/j.neurot.2024.e00504.","journal-title":"Neurotherapeutics"},{"issue":"3","key":"455_CR48","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.surneu.2006.06.025","volume":"66","author":"JM Mira","year":"2006","unstructured":"Mira JM, Costa FA, Horta BL, Fabi\u00e3o OM. Risk of rupture in unruptured anterior communicating artery aneurysms: meta-analysis of natural history studies. Surg Neurol. 2006;66(3):12\u20139. https:\/\/doi.org\/10.1016\/j.surneu.2006.06.025.","journal-title":"Surg Neurol"},{"issue":"12","key":"455_CR49","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nrneurol.2016.150","volume":"12","author":"N Etminan","year":"2016","unstructured":"Etminan N, Rinkel GJ. Unruptured intracranial aneurysms: development, rupture and preventive management. Nat Rev Neurol. 2016;12(12):699\u2013713. https:\/\/doi.org\/10.1038\/nrneurol.2016.150.","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"455_CR50","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1161\/strokeaha.110.586826","volume":"41","author":"R Dodel","year":"2010","unstructured":"Dodel R, Winter Y, Ringel F, Spottke A, Gharevi N, M\u00fcller I, et al. Cost of illness in subarachnoid hemorrhage: a German longitudinal study. Stroke. 2010;41(12):2918\u201323. https:\/\/doi.org\/10.1161\/strokeaha.110.586826.","journal-title":"Stroke"},{"issue":"1","key":"455_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7547-8-6","volume":"8","author":"O Rivero-Arias","year":"2010","unstructured":"Rivero-Arias O, Gray A, Wolstenholme J. Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom. Cost Eff Resour Alloc. 2010;8(1):6. https:\/\/doi.org\/10.1186\/1478-7547-8-6.","journal-title":"Cost Eff Resour Alloc"},{"issue":"8","key":"455_CR52","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1001\/jamaneurol.2025.1522","volume":"82","author":"Collaborators G G S H R F","year":"2025","unstructured":"Collaborators G G S H R F. Global, regional, and national burden of nontraumatic subarachnoid hemorrhage: the Global Burden of Disease Study 2021. JAMA Neurol. 2025;82(8):765\u201387. https:\/\/doi.org\/10.1001\/jamaneurol.2025.1522.","journal-title":"JAMA Neurol"},{"issue":"5","key":"455_CR53","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/svn-2021-001374","volume":"7","author":"YJ Wang","year":"2022","unstructured":"Wang YJ, Li ZX, Gu HQ, Zhai Y, Zhou Q, Jiang Y, et al. China stroke statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations. Stroke Vasc Neurol. 2022;7(5):415\u201350. https:\/\/doi.org\/10.1136\/svn-2021-001374.","journal-title":"Stroke Vasc Neurol"},{"key":"455_CR54","doi-asserted-by":"publisher","unstructured":"Medina-Su\u00e1rez J, Rodr\u00edguez-Esparrag\u00f3n F, Sosa-P\u00e9rez C, Cazorla-Rivero S, Torres-Mata L B, Jim\u00e9nez-O'shanahan A, et al. A Review of Genetic Polymorphisms and Susceptibilities to Complications after Aneurysmal Subarachnoid Hemorrhage. Int J Mol Sci. 2022;23(23). https:\/\/doi.org\/10.3390\/ijms232315427.","DOI":"10.3390\/ijms232315427"},{"issue":"1","key":"455_CR55","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/neurolint16010015","volume":"16","author":"M Uemura","year":"2024","unstructured":"Uemura M, Tanaka N, Ando S, Yanagihara T, Onodera O. Missense variants in COL4A1\/2 are associated with cerebral aneurysms: a case report and literature review. Neurol Int. 2024;16(1):226\u201338. https:\/\/doi.org\/10.3390\/neurolint16010015.","journal-title":"Neurol Int"},{"key":"455_CR56","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejpn.2021.10.011","volume":"36","author":"W Fazeli","year":"2022","unstructured":"Fazeli W, Bamborschke D, Moawia A, Bakhtiari S, Tafakhori A, Giersdorf M, et al. The phenotypic spectrum of PCDH12 associated disorders - Five new cases and review of the literature. Eur J Paediatr Neurol. 2022;36:7\u201313. https:\/\/doi.org\/10.1016\/j.ejpn.2021.10.011.","journal-title":"Eur J Paediatr Neurol"},{"issue":"1","key":"455_CR57","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2176\/nmc.oa.2017-0138","volume":"58","author":"JP Jeon","year":"2018","unstructured":"Jeon JP, Hong EP, Kim JE, Ha EJ, Cho WS, Son YJ, et al. Genetic Risk Assessment of Elastin Gene Polymorphisms with Intracranial Aneurysm in Koreans. Neurol Med Chir (Tokyo). 2018;58(1):17\u201322. https:\/\/doi.org\/10.2176\/nmc.oa.2017-0138.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"4","key":"455_CR58","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s12017-019-08537-7","volume":"21","author":"Z Xu","year":"2019","unstructured":"Xu Z, Rui YN, Hagan JP, Kim DH. Intracranial aneurysms: pathology, genetics, and molecular mechanisms. Neuromol Med. 2019;21(4):325\u201343. https:\/\/doi.org\/10.1007\/s12017-019-08537-7.","journal-title":"Neuromol Med"},{"issue":"5","key":"455_CR59","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3340\/jkns.2023.0001","volume":"66","author":"EP Hong","year":"2023","unstructured":"Hong EP, Cho SM, Rhim JK, Park JJ, Ahn JH, Youn DH, et al. Updated Trans-Ethnic Meta-Analysis of Associations between Inflammation-Related Genes and Intracranial Aneurysm. J Korean Neurosurg Soc. 2023;66(5):525\u201335. https:\/\/doi.org\/10.3340\/jkns.2023.0001.","journal-title":"J Korean Neurosurg Soc"},{"issue":"11","key":"455_CR60","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000210052","volume":"103","author":"IM Rautalin","year":"2024","unstructured":"Rautalin IM, Asikainen A, Korja M. Modifiable risk factors for subarachnoid hemorrhage: narrative review with an emphasis on common controversies and epidemiologic pitfalls. Neurology. 2024;103(11):e210052. https:\/\/doi.org\/10.1212\/wnl.0000000000210052.","journal-title":"Neurology"},{"issue":"12","key":"455_CR61","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1161\/01.STR.0000190838.02954.e8","volume":"36","author":"VL Feigin","year":"2005","unstructured":"Feigin VL, Rinkel GJ, Lawes CM, Algra A, Bennett DA, Van Gijn J, et al. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke. 2005;36(12):2773\u201380. https:\/\/doi.org\/10.1161\/01.STR.0000190838.02954.e8.","journal-title":"Stroke"},{"key":"455_CR62","doi-asserted-by":"publisher","unstructured":"Van Hespen KM, Mackaaij C, Waas ISE, De Bree MP, Zwanenburg JJM, Kuijf HJ, et al. Arterial remodeling of the intracranial arteries in patients with hypertension and controls. Hypertension. 2021;77(1):135\u2013146. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.16029.","DOI":"10.1161\/HYPERTENSIONAHA.120.16029"},{"issue":"4","key":"455_CR63","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/hr.2016.145","volume":"40","author":"RMKW Lee","year":"2017","unstructured":"Lee RMKW, Dickhout JG, Sandow SL. Vascular structural and functional changes: their association with causality in hypertension: models, remodeling and relevance. Hypertens Res. 2017;40(4):311\u201323. https:\/\/doi.org\/10.1038\/hr.2016.145.","journal-title":"Hypertens Res"},{"key":"455_CR64","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/808353","volume":"2013","author":"NF Renna","year":"2013","unstructured":"Renna NF, De Las Heras N, Miatello RM. Pathophysiology of vascular remodeling in hypertension. Int J Hypertens. 2013;2013:808353. https:\/\/doi.org\/10.1155\/2013\/808353.","journal-title":"Int J Hypertens"},{"key":"455_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.1021540","volume":"9","author":"H Xu","year":"2022","unstructured":"Xu H, He Y, Hong T, Bi C, Li J, Xia M. Piezo1 in vascular remodeling of atherosclerosis and pulmonary arterial hypertension: a potential therapeutic target. Front Cardiovasc Med. 2022;9:1021540. https:\/\/doi.org\/10.3389\/fcvm.2022.1021540.","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"455_CR66","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.celrep.2015.09.072","volume":"13","author":"K Retailleau","year":"2015","unstructured":"Retailleau K, Duprat F, Arhatte M, Ranade SS, Peyronnet R, Martins JR, et al. Piezo1 in Smooth Muscle Cells Is Involved in Hypertension-Dependent Arterial Remodeling. Cell Rep. 2015;13(6):1161\u201371. https:\/\/doi.org\/10.1016\/j.celrep.2015.09.072.","journal-title":"Cell Rep"},{"issue":"3","key":"455_CR67","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1161\/ATVBAHA.117.310478","volume":"38","author":"RM Starke","year":"2018","unstructured":"Starke RM, Thompson JW, Ali MS, Pascale CL, Martinez Lege A, Ding D, et al. Cigarette smoke initiates oxidative stress-induced cellular phenotypic modulation leading to cerebral aneurysm pathogenesis. Arterioscler Thromb Vasc Biol. 2018;38(3):610\u201321.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"455_CR68","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/271582","volume":"2012","author":"N Chalouhi","year":"2012","unstructured":"Chalouhi N, Ali MS, Starke RM, Jabbour PM, Tjoumakaris SI, Gonzalez LF, et al. Cigarette smoke and inflammation: role in cerebral aneurysm formation and rupture. Mediators Inflamm. 2012;2012:271582. https:\/\/doi.org\/10.1155\/2012\/271582.","journal-title":"Mediators Inflamm"},{"key":"455_CR69","doi-asserted-by":"publisher","unstructured":"Feng X, Qian Z, Zhang B, Guo E, Wang L, Liu P, et al. Number of Cigarettes Smoked Per Day, Smoking Index, and Intracranial Aneurysm Rupture: A Case\u2013Control Study. Front Neurol. 2018;(9). https:\/\/doi.org\/10.3389\/fneur.2018.00380.","DOI":"10.3389\/fneur.2018.00380"},{"issue":"9","key":"455_CR70","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3390\/jcm8091295","volume":"8","author":"A Tsatsakis","year":"2019","unstructured":"Tsatsakis A, Docea AO, Calina D, Tsarouhas K, Zamfira L-M, Mitrut R, et al. A Mechanistic and Pathophysiological Approach for Stroke Associated with Drugs of Abuse. J Clin Med. 2019;8(9):1295.","journal-title":"J Clin Med"},{"issue":"3","key":"455_CR71","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.hest.2020.11.002","volume":"2","author":"YW Haddad","year":"2021","unstructured":"Haddad YW, Korcari E, Polsinelli GN, Yuchuan D. The effect of cocaine and methamphetamine on saccular aneurysm formation and rupture: a literature review. Brain Hemorrhages. 2021;2(3):111\u20135. https:\/\/doi.org\/10.1016\/j.hest.2020.11.002.","journal-title":"Brain Hemorrhages"},{"issue":"4","key":"455_CR72","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3892\/br.2016.743","volume":"5","author":"X Yao","year":"2016","unstructured":"Yao X, Zhang K, Bian J, Chen G. Alcohol consumption and risk of subarachnoid hemorrhage: a meta-analysis of 14 observational studies. Biomed Rep. 2016;5(4):428\u201336. https:\/\/doi.org\/10.3892\/br.2016.743.","journal-title":"Biomed Rep"},{"issue":"11","key":"455_CR73","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.3390\/medicina60111813","volume":"60","author":"VM Swiatek","year":"2024","unstructured":"Swiatek VM, Fischer I, Khajuria R, Amini A, Steinkusch H, Rashidi A, et al. The MARVIN Hypothesis: Linking Unhealthy Lifestyles to Intracranial Aneurysm Rupture Risk and Clinical Prognosis. Medicina. 2024;60(11):1813.","journal-title":"Medicina"},{"issue":"4","key":"455_CR74","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1161\/strokeaha.121.034782","volume":"53","author":"I Rautalin","year":"2022","unstructured":"Rautalin I, Kaprio J, Ingebrigtsen T, Jousilahti P, L\u00f8chen ML, Romundstad PR, et al. Obesity Does Not Protect From Subarachnoid Hemorrhage: Pooled Analyses of 3 Large Prospective Nordic Cohorts. Stroke. 2022;53(4):1301\u20139. https:\/\/doi.org\/10.1161\/strokeaha.121.034782.","journal-title":"Stroke"},{"issue":"8","key":"455_CR75","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1161\/STROKEAHA.122.038776","volume":"53","author":"AN Martinez","year":"2022","unstructured":"Martinez AN, Tortelote GG, Pascale CL, Mccormack IG, Nordham KD, Suder NJ, et al. Single-cell transcriptome analysis of the circle of Willis in a mouse cerebral aneurysm model. Stroke. 2022;53(8):2647\u201357.","journal-title":"Stroke"},{"issue":"4","key":"455_CR76","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1093\/cvr\/cvae186","volume":"121","author":"G Yu","year":"2024","unstructured":"Yu G, Li J, Zhang H, Zi H, Liu M, An Q, et al. Single-cell analysis reveals the implication of vascular endothelial cell-intrinsic ANGPT2 in human intracranial aneurysm. Cardiovasc Res. 2024;121(4):658\u201373. https:\/\/doi.org\/10.1093\/cvr\/cvae186.","journal-title":"Cardiovasc Res"},{"key":"455_CR77","doi-asserted-by":"publisher","unstructured":"Zhang E, Yan X, Shen H, Zhao M, Gao X, Huang Y. Intracranial Aneurysm Biomarkers: A Convergence of Genetics, Inflammation, Oxidative Stress, and the Extracellular Matrix. Int J Mol Sci. 2025;26(7). https:\/\/doi.org\/10.3390\/ijms26073316.","DOI":"10.3390\/ijms26073316"},{"issue":"2","key":"455_CR78","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/cei\/uxae042","volume":"217","author":"Y Yu","year":"2024","unstructured":"Yu Y, Tong S, Liu T, Cai Y, Song Y, Zhou H, et al. Exploring the causal role of immune cells in cerebral aneurysm through single-cell transcriptomics and Mendelian randomization analysis. Clin Exp Immunol. 2024;217(2):195\u2013203. https:\/\/doi.org\/10.1093\/cei\/uxae042.","journal-title":"Clin Exp Immunol"},{"key":"455_CR79","doi-asserted-by":"publisher","unstructured":"Blaj LA, Cucu AI, Tamba BI,Turliuc MD. The Role of the NF-kB Pathway in Intracranial Aneurysms. Brain Sci. 2023;13(12). https:\/\/doi.org\/10.3390\/brainsci13121660.","DOI":"10.3390\/brainsci13121660"},{"issue":"3","key":"455_CR80","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4331\/wjbc.v3.i3.41","volume":"3","author":"X Guo","year":"2012","unstructured":"Guo X, Chen SY. Transforming growth factor-\u03b2 and smooth muscle differentiation. World J Biol Chem. 2012;3(3):41\u201352. https:\/\/doi.org\/10.4331\/wjbc.v3.i3.41.","journal-title":"World J Biol Chem"},{"issue":"1","key":"455_CR81","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-021-04079-z","volume":"79","author":"F Zhang","year":"2021","unstructured":"Zhang F, Guo X, Xia Y, Mao L. An update on the phenotypic switching of vascular smooth muscle cells in the pathogenesis of atherosclerosis. Cell Mol Life Sci. 2021;79(1):6. https:\/\/doi.org\/10.1007\/s00018-021-04079-z.","journal-title":"Cell Mol Life Sci"},{"key":"455_CR82","doi-asserted-by":"publisher","unstructured":"Xie Y, Li X, Yu Z, Kong Q, Zhou X, Zhang Y, et al. Inflammatory biomarkers in patients with intracranial aneurysms. Brain Hemorrhages. 2025. https:\/\/doi.org\/10.1016\/j.hest.2025.09.005.","DOI":"10.1016\/j.hest.2025.09.005"},{"issue":"1","key":"455_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01609-2","volume":"29","author":"J Fang","year":"2024","unstructured":"Fang J, Cao Y, Ni J. Circulating inflammatory biomarkers and risk of intracranial aneurysm: a Mendelian randomization study. Eur J Med Res. 2024;29(1):17. https:\/\/doi.org\/10.1186\/s40001-023-01609-2.","journal-title":"Eur J Med Res"},{"issue":"6","key":"455_CR84","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/HJH.0b013e328329d1a7","volume":"27","author":"T Tamura","year":"2009","unstructured":"Tamura T, Jamous MA, Kitazato KT, Yagi K, Tada Y, Uno M, et al. Endothelial damage due to impaired nitric oxide bioavailability triggers cerebral aneurysm formation in female rats. J Hypertens. 2009;27(6):1284\u201392. https:\/\/doi.org\/10.1097\/HJH.0b013e328329d1a7.","journal-title":"J Hypertens"},{"issue":"1","key":"455_CR85","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.3171\/2019.4.Focus19221","volume":"47","author":"DL Sheinberg","year":"2019","unstructured":"Sheinberg DL, Mccarthy DJ, Elwardany O, Bryant JP, Luther E, Chen SH, et al. Endothelial dysfunction in cerebral aneurysms. Neurosurg Focus. 2019;47(1):E3. https:\/\/doi.org\/10.3171\/2019.4.Focus19221.","journal-title":"Neurosurg Focus"},{"key":"455_CR86","doi-asserted-by":"publisher","unstructured":"Fr\u00e9neau M, Baron-Menguy C, Vion A-C, Loirand G. Why Are Women Predisposed to Intracranial Aneurysm? Front Cardiovasc Med. 2022;(9). https:\/\/doi.org\/10.3389\/fcvm.2022.815668.","DOI":"10.3389\/fcvm.2022.815668"},{"issue":"14","key":"455_CR87","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.3390\/jcm13144255","volume":"13","author":"G Buso","year":"2024","unstructured":"Buso G, Corvini F, Fusco EM, Messina M, Cherubini F, Laera N, et al. Current Evidence and Future Perspectives in the Medical Management of Vascular Ehlers-Danlos Syndrome: Focus on Vascular Prevention. J Clin Med. 2024;13(14):4255.","journal-title":"J Clin Med"},{"issue":"3","key":"455_CR88","doi-asserted-by":"publisher","first-page":"302","DOI":"10.5853\/jos.2025.01662","volume":"27","author":"YS Kim","year":"2025","unstructured":"Kim YS, Hwang S, Kim MH, Kwon B, Song Y, Lee DH. Time to Consider Pharmacologic Management of Unruptured Intracranial Aneurysms? J Stroke. 2025;27(3):302\u201312. https:\/\/doi.org\/10.5853\/jos.2025.01662.","journal-title":"J Stroke"},{"issue":"10355","key":"455_CR89","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/s0140-6736(22)00938-2","volume":"400","author":"J Claassen","year":"2022","unstructured":"Claassen J, Park S. Spontaneous subarachnoid haemorrhage. Lancet. 2022;400(10355):846\u201362. https:\/\/doi.org\/10.1016\/s0140-6736(22)00938-2.","journal-title":"Lancet"},{"issue":"5","key":"455_CR90","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1161\/STROKEAHA.122.040072","volume":"54","author":"DC Lauzier","year":"2023","unstructured":"Lauzier DC, Jayaraman K, Yuan JY, Diwan D, Vellimana AK, Osbun JW, et al. Early brain injury after subarachnoid hemorrhage: incidence and mechanisms. Stroke. 2023;54(5):1426\u201340. https:\/\/doi.org\/10.1161\/STROKEAHA.122.040072.","journal-title":"Stroke"},{"issue":"1","key":"455_CR91","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11910-024-01396-1","volume":"25","author":"BSK Yang","year":"2024","unstructured":"Yang BSK, Gusdon AM, Ren XS, Jeong HG, Lee CH, Blackburn S, et al. Update on Strategies to Reduce Early Brain Injury after Subarachnoid Hemorrhage. Curr Neurol Neurosci Rep. 2024;25(1):14. https:\/\/doi.org\/10.1007\/s11910-024-01396-1.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"455_CR92","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40635-014-0030-1","volume":"2","author":"S Marbacher","year":"2014","unstructured":"Marbacher S, Neuschmelting V, Andereggen L, Widmer HR, Von Gunten M, Takala J, et al. Early brain injury linearly correlates with reduction in cerebral perfusion pressure during the hyperacute phase of subarachnoid hemorrhage. Intensive Care Med Exp. 2014;2(1):30. https:\/\/doi.org\/10.1186\/s40635-014-0030-1.","journal-title":"Intensive Care Med Exp"},{"key":"455_CR93","doi-asserted-by":"publisher","unstructured":"Stragier H, Vandersmissen H, Ordies S, Thiessen S, Mesotten D, Peuskens D, et al. Pathophysiological mechanisms underlying early brain injury and delayed cerebral ischemia in the aftermath of aneurysmal subarachnoid hemorrhage: a comprehensive analysis. Front Neurol. 2025;(16). https:\/\/doi.org\/10.3389\/fneur.2025.1587091.","DOI":"10.3389\/fneur.2025.1587091"},{"key":"455_CR94","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/651958","volume":"2013","author":"N Plesnila","year":"2013","unstructured":"Plesnila N. Pathophysiological role of global cerebral ischemia following subarachnoid hemorrhage: the current experimental evidence. Stroke Res Treat. 2013;2013:651958. https:\/\/doi.org\/10.1155\/2013\/651958.","journal-title":"Stroke Res Treat"},{"issue":"12","key":"455_CR95","doi-asserted-by":"publisher","first-page":"10736","DOI":"10.1007\/s12035-024-04218-0","volume":"61","author":"S Ge","year":"2024","unstructured":"Ge S, Jing Z, Wang L, Cui X, Zhang X, Wang X. Iron Metabolism and Ferroptosis in Early Brain Injury after Subarachnoid Haemorrhage. Mol Neurobiol. 2024;61(12):10736\u201346. https:\/\/doi.org\/10.1007\/s12035-024-04218-0.","journal-title":"Mol Neurobiol"},{"issue":"10","key":"455_CR96","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1161\/01.STR.31.10.2450","volume":"31","author":"PG Matz","year":"2000","unstructured":"Matz PG, Copin J-C, Chan PH. Cell death after exposure to subarachnoid hemolysate correlates inversely with expression of CuZn\u2013superoxide dismutase. Stroke. 2000;31(10):2450\u20139. https:\/\/doi.org\/10.1161\/01.STR.31.10.2450.","journal-title":"Stroke"},{"key":"455_CR97","doi-asserted-by":"publisher","unstructured":"Garton T, Keep R F, Hua Y, Xi G. Brain iron overload following intracranial haemorrhage. Stroke Vasc Neurol. 2016;1(4). https:\/\/doi.org\/10.1136\/svn-2016-000042.","DOI":"10.1136\/svn-2016-000042"},{"issue":"1","key":"455_CR98","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s12028-021-01278-1","volume":"36","author":"R Helbok","year":"2022","unstructured":"Helbok R, Rass V, Kofler M, Talasz H, Schiefecker A, Gaasch M, et al. Intracerebral Iron Accumulation may be Associated with Secondary Brain Injury in Patients with Poor Grade Subarachnoid Hemorrhage. Neurocrit Care. 2022;36(1):171\u20139. https:\/\/doi.org\/10.1007\/s12028-021-01278-1.","journal-title":"Neurocrit Care"},{"key":"455_CR99","doi-asserted-by":"publisher","unstructured":"Wang X-Y, Wu F, Zhan R-Y, Zhou H-J. Inflammatory role of microglia in brain injury caused by subarachnoid hemorrhage. Front Cell Neurosci. 2022;(16). https:\/\/doi.org\/10.3389\/fncel.2022.956185.","DOI":"10.3389\/fncel.2022.956185"},{"issue":"11","key":"455_CR100","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1161\/strokeaha.125.051215","volume":"56","author":"B Gaastra","year":"2025","unstructured":"Gaastra B, Coy L, Zolnourian A, Holton P, Galea I, Skipp P, et al. A Proteomic Discovery Study of Cerebrospinal Fluid After Aneurysmal Subarachnoid Hemorrhage. Stroke. 2025;56(11):3235\u201344. https:\/\/doi.org\/10.1161\/strokeaha.125.051215.","journal-title":"Stroke"},{"key":"455_CR101","doi-asserted-by":"publisher","unstructured":"Wang G, Huang K, Tian Q, Guo Y, Liu C, Li Z, et al. S100A9 aggravates early brain injury after subarachnoid hemorrhage via inducing neuroinflammation and inflammasome activation. iScience. 2024;27(3):109165. https:\/\/doi.org\/10.1016\/j.isci.2024.109165.","DOI":"10.1016\/j.isci.2024.109165"},{"issue":"1","key":"455_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-022-00312-4","volume":"19","author":"P Sol\u00e1r","year":"2022","unstructured":"Sol\u00e1r P, Zamani A, Lakatosov\u00e1 K, Joukal M. The blood\u2013brain barrier and the neurovascular unit in subarachnoid hemorrhage: molecular events and potential treatments. Fluids and Barriers of the CNS. 2022;19(1):29. https:\/\/doi.org\/10.1186\/s12987-022-00312-4.","journal-title":"Fluids and Barriers of the CNS"},{"issue":"7","key":"455_CR103","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.2174\/1570159x19666211101103646","volume":"20","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Zhang A, Liu Y, Hu X, Fang Y, Wang X, et al. New Mechanisms and Targets of Subarachnoid Hemorrhage: A Focus on Mitochondria. Curr Neuropharmacol. 2022;20(7):1278\u201396. https:\/\/doi.org\/10.2174\/1570159x19666211101103646.","journal-title":"Curr Neuropharmacol"},{"key":"455_CR104","doi-asserted-by":"publisher","unstructured":"Deng X, Wu Y, Hu Z, Wang S, Zhou S, Zhou C, et al. The mechanism of ferroptosis in early brain injury after subarachnoid hemorrhage. Front Immunol. 2023;(14). https:\/\/doi.org\/10.3389\/fimmu.2023.1191826.","DOI":"10.3389\/fimmu.2023.1191826"},{"key":"455_CR105","doi-asserted-by":"publisher","unstructured":"Wu F, Liu Z, Li G, Zhou L, Huang K, Wu Z, et al. Inflammation and Oxidative Stress: Potential Targets for Improving Prognosis After Subarachnoid Hemorrhage. Front Cell Neurosci. 2021;15:739506. https:\/\/doi.org\/10.3389\/fncel.2021.739506.","DOI":"10.3389\/fncel.2021.739506"},{"issue":"9","key":"455_CR106","doi-asserted-by":"publisher","first-page":"7832","DOI":"10.3390\/ijms24097832","volume":"24","author":"F Tartara","year":"2023","unstructured":"Tartara F, Montalbetti A, Crobeddu E, Armocida D, Tavazzi E, Cardia A, et al. Compartmental Cerebrospinal Fluid Events Occurring after Subarachnoid Hemorrhage: An \u201cHeparin Oriented\u201d Systematic Review. Int J Mol Sci. 2023;24(9):7832.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"455_CR107","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s12975-013-0257-2","volume":"4","author":"M Fujii","year":"2013","unstructured":"Fujii M, Yan J, Rolland WB, Soejima Y, Caner B, Zhang JH. Early brain injury, an evolving frontier in subarachnoid hemorrhage research. Transl Stroke Res. 2013;4(4):432\u201346. https:\/\/doi.org\/10.1007\/s12975-013-0257-2.","journal-title":"Transl Stroke Res"},{"issue":"15","key":"455_CR108","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.121.021845","volume":"10","author":"WS Dodd","year":"2021","unstructured":"Dodd WS, Laurent D, Dumont AS, Hasan DM, Jabbour PM, Starke RM, et al. Pathophysiology of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: A Review. J Am Heart Assoc. 2021;10(15):e021845. https:\/\/doi.org\/10.1161\/jaha.121.021845.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"455_CR109","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1038\/s41467-024-46015-2","volume":"15","author":"S Thilak","year":"2024","unstructured":"Thilak S, Brown P, Whitehouse T, Gautam N, Lawrence E, Ahmed Z, et al. Diagnosis and management of subarachnoid haemorrhage. Nat Commun. 2024;15(1):1850. https:\/\/doi.org\/10.1038\/s41467-024-46015-2.","journal-title":"Nat Commun"},{"issue":"8","key":"455_CR110","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1177\/0271678x18774666","volume":"38","author":"RF Keep","year":"2018","unstructured":"Keep RF, Andjelkovic AV, Xiang J, Stamatovic SM, Antonetti DA, Hua Y, et al. Brain endothelial cell junctions after cerebral hemorrhage: Changes, mechanisms and therapeutic targets. J Cereb Blood Flow Metab. 2018;38(8):1255\u201375. https:\/\/doi.org\/10.1177\/0271678x18774666.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"455_CR111","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1161\/strokeaha.115.010351","volume":"46","author":"Y Egashira","year":"2015","unstructured":"Egashira Y, Zhao H, Hua Y, Keep RF, Xi G. White matter injury after subarachnoid hemorrhage: role of blood-brain barrier disruption and matrix metalloproteinase-9. Stroke. 2015;46(10):2909\u201315. https:\/\/doi.org\/10.1161\/strokeaha.115.010351.","journal-title":"Stroke"},{"key":"455_CR112","doi-asserted-by":"publisher","unstructured":"Wang X, Wen D, You C, Ma L. Identification of the key immune-related genes in aneurysmal subarachnoid hemorrhage. Frontiers in Molecular Neuroscience. 2022;(15). https:\/\/doi.org\/10.3389\/fnmol.2022.931753.","DOI":"10.3389\/fnmol.2022.931753"},{"issue":"6","key":"455_CR113","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.3390\/biomedicines13061406","volume":"13","author":"S Kokkoris","year":"2025","unstructured":"Kokkoris S, Vrettou CS, Lotsios NS, Issaris V, Keskinidou C, Papavassiliou KA, et al. Aquaporins in Acute Brain Injury: Insights from Clinical and Experimental Studies. Biomedicines. 2025;13(6):1406.","journal-title":"Biomedicines"},{"issue":"10","key":"455_CR114","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-019-0990-3","volume":"19","author":"V Rass","year":"2019","unstructured":"Rass V, Helbok R. Early brain injury after poor-grade subarachnoid hemorrhage. Curr Neurol Neurosci Rep. 2019;19(10):78. https:\/\/doi.org\/10.1007\/s11910-019-0990-3.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"4","key":"455_CR115","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10571-014-0150-x","volume":"35","author":"ZY Zhang","year":"2015","unstructured":"Zhang ZY, Yang MF, Wang T, Li DW, Liu YL, Zhang JH, et al. Cysteamine alleviates early brain injury via reducing oxidative stress and apoptosis in a rat experimental subarachnoid hemorrhage model. Cell Mol Neurobiol. 2015;35(4):543\u201353. https:\/\/doi.org\/10.1007\/s10571-014-0150-x.","journal-title":"Cell Mol Neurobiol"},{"key":"455_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2024.111183","volume":"220","author":"Y Yao","year":"2025","unstructured":"Yao Y, Wu Q, Yuan K, Wu P, Xu C, Ji Z, et al. Bindarit attenuates neuroinflammation after subarachnoid hemorrhage by regulating the CCL2\/CCR2\/NF-\u03baB pathway. Brain Res Bull. 2025;220:111183. https:\/\/doi.org\/10.1016\/j.brainresbull.2024.111183.","journal-title":"Brain Res Bull"},{"issue":"12","key":"455_CR117","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1038\/jcbfm.2013.173","volume":"33","author":"L \u00d8stergaard","year":"2013","unstructured":"\u00d8stergaard L, Aamand R, Karabegovic S, Tietze A, Blicher JU, Mikkelsen IK, et al. The role of the microcirculation in delayed cerebral ischemia and chronic degenerative changes after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2013;33(12):1825\u201337. https:\/\/doi.org\/10.1038\/jcbfm.2013.173.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"455_CR118","doi-asserted-by":"publisher","first-page":"143","DOI":"10.14670\/hh-18-253","volume":"36","author":"H Suzuki","year":"2021","unstructured":"Suzuki H, Kanamaru H, Kawakita F, Asada R, Fujimoto M, Shiba M. Cerebrovascular pathophysiology of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Histol Histopathol. 2021;36(2):143\u201358. https:\/\/doi.org\/10.14670\/hh-18-253.","journal-title":"Histol Histopathol"},{"key":"455_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2022.107273","volume":"218","author":"K Motwani","year":"2022","unstructured":"Motwani K, Dodd WS, Laurent D, Lucke-Wold B, Chalouhi N. Delayed cerebral ischemia: a look at the role of endothelial dysfunction, emerging endovascular management, and glymphatic clearance. Clin Neurol Neurosurg. 2022;218:107273. https:\/\/doi.org\/10.1016\/j.clineuro.2022.107273.","journal-title":"Clin Neurol Neurosurg"},{"issue":"11","key":"455_CR120","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/jcbfm.2008.74","volume":"28","author":"MD Vergouwen","year":"2008","unstructured":"Vergouwen MD, Vermeulen M, Coert BA, Stroes ES, Roos YB. Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab. 2008;28(11):1761\u201370. https:\/\/doi.org\/10.1038\/jcbfm.2008.74.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"455_CR121","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/0271678x211045446","volume":"42","author":"M Naraoka","year":"2022","unstructured":"Naraoka M, Matsuda N, Shimamura N, Ohkuma H. Role of microcirculatory impairment in delayed cerebral ischemia and outcome after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2022;42(1):186\u201396. https:\/\/doi.org\/10.1177\/0271678x211045446.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"455_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24129883","volume":"24","author":"A Mehra","year":"2023","unstructured":"Mehra A, Gomez F, Bischof H, Diedrich D, Laudanski K. Cortical spreading depolarization and delayed cerebral ischemia; rethinking secondary neurological injury in subarachnoid hemorrhage. Int J Mol Sci. 2023;24(12):9883.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"455_CR123","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/archneurol.2010.226","volume":"68","author":"LZ Leng","year":"2011","unstructured":"Leng LZ, Fink ME, Iadecola C. Spreading depolarization: a possible new culprit in the delayed cerebral ischemia of subarachnoid hemorrhage. Arch Neurol. 2011;68(1):31\u20136. https:\/\/doi.org\/10.1001\/archneurol.2010.226.","journal-title":"Arch Neurol"},{"issue":"2","key":"455_CR124","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s13311-020-00850-5","volume":"17","author":"K Sugimoto","year":"2020","unstructured":"Sugimoto K, Chung DY. Spreading depolarizations and subarachnoid hemorrhage. Neurotherapeutics. 2020;17(2):497\u2013510. https:\/\/doi.org\/10.1007\/s13311-020-00850-5.","journal-title":"Neurotherapeutics"},{"issue":"1","key":"455_CR125","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12974-019-1578-1","volume":"16","author":"S-H Ahn","year":"2019","unstructured":"Ahn S-H, Savarraj JPJ, Parsha K, Hergenroeder GW, Chang TR, Kim DH, et al. Inflammation in delayed ischemia and functional outcomes after subarachnoid hemorrhage. J Neuroinflammation. 2019;16(1):213. https:\/\/doi.org\/10.1186\/s12974-019-1578-1.","journal-title":"J Neuroinflammation"},{"key":"455_CR126","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1027756","volume":"13","author":"J Jin","year":"2022","unstructured":"Jin J, Duan J, Du L, Xing W, Peng X, Zhao Q. Inflammation and immune cell abnormalities in intracranial aneurysm subarachnoid hemorrhage (SAH): relevant signaling pathways and therapeutic strategies. Front Immunol. 2022;13:1027756. https:\/\/doi.org\/10.3389\/fimmu.2022.1027756.","journal-title":"Front Immunol"},{"issue":"1","key":"455_CR127","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12953-024-00236-x","volume":"22","author":"R Ding","year":"2024","unstructured":"Ding R, Wu L, Wei S, Lu H, Qin X, Liu X, et al. Multi-targeted olink proteomics analyses of cerebrospinal fluid from patients with aneurysmal subarachnoid hemorrhage. Proteome Sci. 2024;22(1):11. https:\/\/doi.org\/10.1186\/s12953-024-00236-x.","journal-title":"Proteome Sci"},{"issue":"1","key":"455_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0675-7","volume":"13","author":"A Niwa","year":"2016","unstructured":"Niwa A, Osuka K, Nakura T, Matsuo N, Watabe T, Takayasu M. Interleukin-6, MCP-1, IP-10, and MIG are sequentially expressed in cerebrospinal fluid after subarachnoid hemorrhage. J Neuroinflammation. 2016;13(1):217. https:\/\/doi.org\/10.1186\/s12974-016-0675-7.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"455_CR129","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0282424","volume":"18","author":"P Vlachogiannis","year":"2023","unstructured":"Vlachogiannis P, Hillered L, Enblad P, Ronne-Engstr\u00f6m E. Elevated levels of several chemokines in the cerebrospinal fluid of patients with subarachnoid hemorrhage are associated with worse clinical outcome. PLoS ONE. 2023;18(3):e0282424. https:\/\/doi.org\/10.1371\/journal.pone.0282424.","journal-title":"PLoS ONE"},{"key":"455_CR130","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/943761","volume":"2013","author":"V Mehta","year":"2013","unstructured":"Mehta V, Russin J, Spirtos A, He S, Adamczyk P, Amar AP, et al. Matrix metalloproteinases in cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Neurol Res Int. 2013;2013:943761. https:\/\/doi.org\/10.1155\/2013\/943761.","journal-title":"Neurol Res Int"},{"key":"455_CR131","doi-asserted-by":"publisher","unstructured":"Mehra A, Gomez F, Bischof H, Diedrich D, Laudanski K. Cortical Spreading Depolarization and Delayed Cerebral Ischemia; Rethinking Secondary Neurological Injury in Subarachnoid Hemorrhage. Int J Mol Sci. 2023;24(12). https:\/\/doi.org\/10.3390\/ijms24129883.","DOI":"10.3390\/ijms24129883"},{"key":"455_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102489","volume":"101","author":"J Tao","year":"2024","unstructured":"Tao J, Li J, Fan X, Jiang C, Wang Y, Qin M, et al. Unraveling the protein post-translational modification landscape: neuroinflammation and neuronal death after stroke. Ageing Res Rev. 2024;101:102489. https:\/\/doi.org\/10.1016\/j.arr.2024.102489.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"455_CR133","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12014-024-09493-6","volume":"21","author":"SD Lolansen","year":"2024","unstructured":"Lolansen SD, Rostgaard N, Olsen MH, Ottenheijm ME, Drici L, Capion T, et al. Proteomic profile and predictive markers of outcome in patients with subarachnoid hemorrhage. Clin Proteomics. 2024;21(1):51. https:\/\/doi.org\/10.1186\/s12014-024-09493-6.","journal-title":"Clin Proteomics"},{"issue":"5","key":"455_CR134","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1007\/s12035-015-9268-1","volume":"53","author":"W Wu","year":"2016","unstructured":"Wu W, Guan Y, Zhao G, Fu XJ, Guo TZ, Liu YT, et al. Elevated IL-6 and TNF-\u03b1 Levels in Cerebrospinal Fluid of Subarachnoid Hemorrhage Patients. Mol Neurobiol. 2016;53(5):3277\u201385. https:\/\/doi.org\/10.1007\/s12035-015-9268-1.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"455_CR135","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s12028-010-9432-4","volume":"13","author":"A Sarrafzadeh","year":"2010","unstructured":"Sarrafzadeh A, Schlenk F, Gericke C, Vajkoczy P. Relevance of cerebral interleukin-6 after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2010;13(3):339\u201346. https:\/\/doi.org\/10.1007\/s12028-010-9432-4.","journal-title":"Neurocrit Care"},{"issue":"2","key":"455_CR136","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.3892\/etm.2017.5553","volume":"15","author":"L Wang","year":"2018","unstructured":"Wang L, Gao Z. Expression of MMP-9 and IL-6 in patients with subarachnoid hemorrhage and the clinical significance. Exp Ther Med. 2018;15(2):1510\u20134. https:\/\/doi.org\/10.3892\/etm.2017.5553.","journal-title":"Exp Ther Med"},{"issue":"2","key":"455_CR137","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3171\/jns.1997.87.2.0215","volume":"87","author":"T Mathiesen","year":"1997","unstructured":"Mathiesen T, Edner G, Ulfarsson E, Andersson B. Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage. J Neurosurg. 1997;87(2):215\u201320. https:\/\/doi.org\/10.3171\/jns.1997.87.2.0215.","journal-title":"J Neurosurg"},{"issue":"2","key":"455_CR138","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/ane.13353","volume":"143","author":"S Bjerkne Wenneberg","year":"2021","unstructured":"Bjerkne Wenneberg S, Odenstedt Herg\u00e8s H, Svedin P, Mallard C, Karlsson T, Adiels M, et al. Association between inflammatory response and outcome after subarachnoid haemorrhage. Acta Neurol Scand. 2021;143(2):195\u2013205. https:\/\/doi.org\/10.1111\/ane.13353.","journal-title":"Acta Neurol Scand"},{"key":"455_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2024.156780","volume":"184","author":"X Hu","year":"2024","unstructured":"Hu X, Zhao M, Wang M, Wang D, Zhu L, Su C, et al. Elevated serum and cerebrospinal fluid levels of interleukin-4 related to poor outcome of aneurysmal subarachnoid hemorrhage. Cytokine. 2024;184:156780. https:\/\/doi.org\/10.1016\/j.cyto.2024.156780.","journal-title":"Cytokine"},{"key":"455_CR140","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1016\/j.wneu.2017.12.076","volume":"111","author":"SY Lv","year":"2018","unstructured":"Lv SY, Wu Q, Liu JP, Shao J, Wen LL, Xue J, et al. Levels of interleukin-1\u03b2, interleukin-18, and tumor necrosis factor-\u03b1 in cerebrospinal fluid of aneurysmal subarachnoid hemorrhage patients may be predictors of early brain injury and clinical prognosis. World Neurosurg. 2018;111:e362\u201373. https:\/\/doi.org\/10.1016\/j.wneu.2017.12.076.","journal-title":"World Neurosurg"},{"key":"455_CR141","doi-asserted-by":"publisher","DOI":"10.3390\/cells13161370","author":"RR Taylor","year":"2024","unstructured":"Taylor RR, Keane RW, Guardiola B, L\u00f3pez-Lage S, Moratinos L, Dietrich WD, et al. Inflammasome proteins are reliable biomarkers of the inflammatory response in aneurysmal subarachnoid hemorrhage. Cells. 2024. https:\/\/doi.org\/10.3390\/cells13161370.","journal-title":"Cells"},{"issue":"5","key":"455_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104770","volume":"29","author":"C Wang","year":"2020","unstructured":"Wang C, Kou Y, Han Y, Li X. Early serum calprotectin (S100A8\/A9) predicts delayed cerebral ischemia and outcomes after aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis. 2020;29(5):104770. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.104770.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"5","key":"455_CR143","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1590\/s0102-86502014000500009","volume":"29","author":"FR Romero","year":"2014","unstructured":"Romero FR, Cataneo DC, Cataneo AJ. C-reactive protein and vasospasm after aneurysmal subarachnoid hemorrhage1. Acta Cir Bras. 2014;29(5):340\u20135. https:\/\/doi.org\/10.1590\/s0102-86502014000500009.","journal-title":"Acta Cir Bras"},{"key":"455_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155142","volume":"133","author":"SR Chaudhry","year":"2020","unstructured":"Chaudhry SR, Kinfe TM, Lamprecht A, Niemel\u00e4 M, Dobreva G, H\u00e4nggi D, et al. Elevated level of cerebrospinal fluid and systemic chemokine CCL5 is a predictive biomarker of clinical outcome after aneurysmal subarachnoid hemorrhage (aSAH). Cytokine. 2020;133:155142. https:\/\/doi.org\/10.1016\/j.cyto.2020.155142.","journal-title":"Cytokine"},{"issue":"1","key":"455_CR145","doi-asserted-by":"publisher","first-page":"10430","DOI":"10.1038\/s41598-024-61185-1","volume":"14","author":"Z Chen","year":"2024","unstructured":"Chen Z, Zou S, Shan H, Liu J, Tian D, Wu X, et al. Longitudinal change of serum AIM2 levels after aneurysmal subarachnoid hemorrhage and its prognostic significance: a two-center prospective cohort study. Sci Rep. 2024;14(1):10430. https:\/\/doi.org\/10.1038\/s41598-024-61185-1.","journal-title":"Sci Rep"},{"issue":"8","key":"455_CR146","doi-asserted-by":"publisher","first-page":"6841","DOI":"10.1007\/s12035-018-0893-3","volume":"55","author":"Y Nakatsuka","year":"2018","unstructured":"Nakatsuka Y, Shiba M, Nishikawa H, Terashima M, Kawakita F, Fujimoto M, et al. Acute-Phase Plasma Osteopontin as an Independent Predictor for Poor Outcome After Aneurysmal Subarachnoid Hemorrhage. Mol Neurobiol. 2018;55(8):6841\u20139. https:\/\/doi.org\/10.1007\/s12035-018-0893-3.","journal-title":"Mol Neurobiol"},{"key":"455_CR147","doi-asserted-by":"publisher","DOI":"10.3390\/cells8070695","author":"MG Abate","year":"2019","unstructured":"Abate MG, Moretto L, Licari I, Esposito T, Capuano L, Olivieri C, et al. Osteopontin in the cerebrospinal fluid of patients with severe aneurysmal subarachnoid hemorrhage. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8070695.","journal-title":"Cells"},{"key":"455_CR148","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jns.2016.02.043","volume":"363","author":"JX Dai","year":"2016","unstructured":"Dai JX, Cai JY, Lin Q, Chen XD, Lu C, Sun J, et al. Thioredoxin as a marker for severity and prognosis of aneurysmal subarachnoid hemorrhage. J Neurol Sci. 2016;363:84\u20139. https:\/\/doi.org\/10.1016\/j.jns.2016.02.043.","journal-title":"J Neurol Sci"},{"key":"455_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2025.105374","volume":"313","author":"S Chen","year":"2025","unstructured":"Chen S, Hu Z, Zhao M, Sun J, Nie S, Gao X, et al. A comprehensive proteomic analysis reveals novel inflammatory biomarkers in intracranial aneurysms. J Proteomics. 2025;313:105374. https:\/\/doi.org\/10.1016\/j.jprot.2025.105374.","journal-title":"J Proteomics"},{"issue":"3","key":"455_CR150","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3171\/jns.2000.92.3.0390","volume":"92","author":"S Juvela","year":"2000","unstructured":"Juvela S. Plasma endothelin concentrations after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2000;92(3):390\u2013400. https:\/\/doi.org\/10.3171\/jns.2000.92.3.0390.","journal-title":"J Neurosurg"},{"issue":"1","key":"455_CR151","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.surneu.2005.04.014","volume":"64","author":"IM Kessler","year":"2005","unstructured":"Kessler IM, Pacheco YG, Lozzi SP, De Ara\u00fajo AS, Onishi FJ, De Mello PA. Endothelin-1 levels in plasma and cerebrospinal fluid of patients with cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Surg Neurol. 2005;64(1):2\u20135. https:\/\/doi.org\/10.1016\/j.surneu.2005.04.014.","journal-title":"Surg Neurol"},{"issue":"5","key":"455_CR152","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1097\/00006123-200211000-00005","volume":"51","author":"MJ Mcgirt","year":"2002","unstructured":"Mcgirt MJ, Lynch JR, Blessing R, Warner DS, Friedman AH, Laskowitz DT. Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2002;51(5):1128\u201334. https:\/\/doi.org\/10.1097\/00006123-200211000-00005.","journal-title":"Neurosurgery"},{"issue":"1-2","key":"455_CR153","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jns.2006.09.005","volume":"251","author":"S Horstmann","year":"2006","unstructured":"Horstmann S, Su Y, Koziol J, Meyding-Lamad\u00e9 U, Nagel S, Wagner S. MMP-2 and MMP-9 levels in peripheral blood after subarachnoid hemorrhage. J Neurol Sci. 2006;251(1\u20132):82\u20136. https:\/\/doi.org\/10.1016\/j.jns.2006.09.005.","journal-title":"J Neurol Sci"},{"issue":"4","key":"455_CR154","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s12975-011-0117-x","volume":"2","author":"SH Chou","year":"2011","unstructured":"Chou SH, Feske SK, Simmons SL, Konigsberg RG, Orzell SC, Marckmann A, et al. Elevated peripheral neutrophils and matrix metalloproteinase 9 as biomarkers of functional outcome following subarachnoid hemorrhage. Transl Stroke Res. 2011;2(4):600\u20137. https:\/\/doi.org\/10.1007\/s12975-011-0117-x.","journal-title":"Transl Stroke Res"},{"issue":"1","key":"455_CR155","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/jnnp.2005.064956","volume":"77","author":"CJ Frijns","year":"2006","unstructured":"Frijns CJ, Fijnheer R, Algra A, Van Mourik JA, Van Gijn J, Rinkel GJ. Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: associations with cerebral ischaemic events and outcome. J Neurol Neurosurg Psychiatry. 2006;77(1):77\u201383. https:\/\/doi.org\/10.1136\/jnnp.2005.064956.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"455_CR156","doi-asserted-by":"publisher","unstructured":"Lim M, Bower RS, Wang Y, Sims L, Bower MR, Camara-Quintana J, et al. The predictive value of serum myeloperoxidase for vasospasm in patients with aneurysmal subarachnoid hemorrhage. Neurosurg Rev. 2012;35(3):413\u20139; discussion 419. https:\/\/doi.org\/10.1007\/s10143-012-0375-4.","DOI":"10.1007\/s10143-012-0375-4"},{"key":"455_CR157","doi-asserted-by":"publisher","unstructured":"Matsumoto A, Nakamura T, Shinomiya A, Kawakita K, Kawanishi M, Miyake K, et al. Histidine-rich Glycoprotein Could Be an Early Predictor of Vasospasm after Aneurysmal Subarachnoid Hemorrhage. Acta Med Okayama. 2019;73(1):29\u201339. https:\/\/doi.org\/10.18926\/amo\/56456.","DOI":"10.18926\/amo\/56456"},{"issue":"1","key":"455_CR158","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3171\/jns\/2008\/109\/7\/0038","volume":"109","author":"GH Kim","year":"2008","unstructured":"Kim GH, Kellner CP, Hahn DK, Desantis BM, Musabbir M, Starke RM, et al. Monocyte chemoattractant protein-1 predicts outcome and vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2008;109(1):38\u201343. https:\/\/doi.org\/10.3171\/jns\/2008\/109\/7\/0038.","journal-title":"J Neurosurg"},{"issue":"10","key":"455_CR159","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1179\/1743132813y.0000000246","volume":"35","author":"KM Schebesch","year":"2013","unstructured":"Schebesch KM, Brawanski A, Bele S, Sch\u00f6del P, Herbst A, Br\u00fcndl E, et al. Neuropeptide Y - an early biomarker for cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurol Res. 2013;35(10):1038\u201343. https:\/\/doi.org\/10.1179\/1743132813y.0000000246.","journal-title":"Neurol Res"},{"issue":"3","key":"455_CR160","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s12028-019-00714-7","volume":"31","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Jiang H, Li Y, Weng Y, Xu K, Zhou L, et al. Serum Alkaline Phosphatase Level is Associated with Angiographic Vasospasm, Delayed Cerebral Ischemia-Caused Clinical Deterioration, and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care. 2019;31(3):466\u201375. https:\/\/doi.org\/10.1007\/s12028-019-00714-7.","journal-title":"Neurocrit Care"},{"issue":"1","key":"455_CR161","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/02688697.2017.1344615","volume":"32","author":"A Kapoor","year":"2018","unstructured":"Kapoor A, Dhandapani S, Gaudihalli S, Dhandapani M, Singh H, Mukherjee KK. Serum albumin level in spontaneous subarachnoid haemorrhage: more than a mere nutritional marker! Br J Neurosurg. 2018;32(1):47\u201352. https:\/\/doi.org\/10.1080\/02688697.2017.1344615.","journal-title":"Br J Neurosurg"},{"issue":"6","key":"455_CR162","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1468-1331.2006.01332.x","volume":"13","author":"PE Vos","year":"2006","unstructured":"Vos PE, Van Gils M, Beems T, Zimmerman C, Verbeek MM. Increased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity. Eur J Neurol. 2006;13(6):632\u20138. https:\/\/doi.org\/10.1111\/j.1468-1331.2006.01332.x.","journal-title":"Eur J Neurol"},{"issue":"5","key":"455_CR163","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1161\/strokeaha.106.478362","volume":"38","author":"K Nyl\u00e9n","year":"2007","unstructured":"Nyl\u00e9n K, Csajbok LZ, Ost M, Rashid A, Blennow K, Nellg\u00e5rd B, et al. Serum glial fibrillary acidic protein is related to focal brain injury and outcome after aneurysmal subarachnoid hemorrhage. Stroke. 2007;38(5):1489\u201394. https:\/\/doi.org\/10.1161\/strokeaha.106.478362.","journal-title":"Stroke"},{"key":"455_CR164","doi-asserted-by":"publisher","unstructured":"Zheng YK, Dong XQ, Du Q, Wang H, Yang DB, Zhu Q, et al. Comparison of plasma copeptin and multiple biomarkers for assessing prognosis of patients with aneurysmal subarachnoid hemorrhage. Clin Chim Acta. 2017;475:64\u201369. https:\/\/doi.org\/10.1016\/j.cca.2017.10.009.","DOI":"10.1016\/j.cca.2017.10.009"},{"issue":"10","key":"455_CR165","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.1007\/s10072-022-06274-7","volume":"43","author":"T Gyldenholm","year":"2022","unstructured":"Gyldenholm T, Hvas CL, Hvas AM, Hviid CVB. Serum glial fibrillary acidic protein (GFAP) predicts outcome after intracerebral and subarachnoid hemorrhage. Neurol Sci. 2022;43(10):6011\u20139. https:\/\/doi.org\/10.1007\/s10072-022-06274-7.","journal-title":"Neurol Sci"},{"issue":"7","key":"455_CR166","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1002\/jnr.22323","volume":"88","author":"SB Lewis","year":"2010","unstructured":"Lewis SB, Wolper R, Chi YY, Miralia L, Wang Y, Yang C, et al. Identification and preliminary characterization of ubiquitin C terminal hydrolase 1 (UCHL1) as a biomarker of neuronal loss in aneurysmal subarachnoid hemorrhage. J Neurosci Res. 2010;88(7):1475\u201384. https:\/\/doi.org\/10.1002\/jnr.22323.","journal-title":"J Neurosci Res"},{"issue":"12","key":"455_CR167","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028938","volume":"6","author":"R Siman","year":"2011","unstructured":"Siman R, Giovannone N, Toraskar N, Frangos S, Stein SC, Levine JM, et al. Evidence that a panel of neurodegeneration biomarkers predicts vasospasm, infarction, and outcome in aneurysmal subarachnoid hemorrhage. PLoS ONE. 2011;6(12):e28938. https:\/\/doi.org\/10.1371\/journal.pone.0028938.","journal-title":"PLoS ONE"},{"issue":"12","key":"455_CR168","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/bf01410976","volume":"139","author":"M Wiesmann","year":"1997","unstructured":"Wiesmann M, Missler U, Hagenstr\u00f6m H, Gottmann D. S-100 protein plasma levels after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien). 1997;139(12):1155\u201360. https:\/\/doi.org\/10.1007\/bf01410976.","journal-title":"Acta Neurochir (Wien)"},{"issue":"8","key":"455_CR169","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1097\/CCM.0b013e3181809750","volume":"36","author":"P Sanchez-Pe\u00f1a","year":"2008","unstructured":"Sanchez-Pe\u00f1a P, Pereira AR, Sourour NA, Biondi A, Lejean L, Colonne C, et al. S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage. Crit Care Med. 2008;36(8):2267\u201373. https:\/\/doi.org\/10.1097\/CCM.0b013e3181809750.","journal-title":"Crit Care Med"},{"key":"455_CR170","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1200-1","volume":"20","author":"H Quintard","year":"2016","unstructured":"Quintard H, Leduc S, Ferrari P, Petit I, Ichai C. Early and persistent high level of PS 100\u03b2 is associated with increased poor neurological outcome in patients with SAH: is there a PS 100\u03b2 threshold for SAH prognosis? Crit Care. 2016;20:33. https:\/\/doi.org\/10.1186\/s13054-016-1200-1.","journal-title":"Crit Care"},{"key":"455_CR171","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.wneu.2017.09.074","volume":"108","author":"T Abboud","year":"2017","unstructured":"Abboud T, Mende KC, Jung R, Czorlich P, Vettorazzi E, Priefler M, et al. Prognostic value of early S100 calcium binding protein B and neuron-specific enolase in patients with poor-grade aneurysmal subarachnoid hemorrhage: a pilot study. World Neurosurg. 2017;108:669\u201375. https:\/\/doi.org\/10.1016\/j.wneu.2017.09.074.","journal-title":"World Neurosurg"},{"key":"455_CR172","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.956043","volume":"13","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Zeng J, Yu S, Zhao Y, Yang X, Zhou Y, et al. Neurofilament light chain and S100B serum levels are associated with disease severity and outcome in patients with aneurysmal subarachnoid hemorrhage. Front Neurol. 2022;13:956043. https:\/\/doi.org\/10.3389\/fneur.2022.956043.","journal-title":"Front Neurol"},{"issue":"4","key":"455_CR173","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1227\/01.Neu.0000255394.77538.Bb","volume":"60","author":"T Kacira","year":"2007","unstructured":"Kacira T, Kemerdere R, Atukeren P, Hanimoglu H, Sanus GZ, Kucur M, et al. Detection of caspase-3, neuron specific enolase, and high-sensitivity C-reactive protein levels in both cerebrospinal fluid and serum of patients after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2007;60(4):674\u20139. https:\/\/doi.org\/10.1227\/01.Neu.0000255394.77538.Bb.","journal-title":"Neurosurgery"},{"issue":"2","key":"455_CR174","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3109\/00207454.2016.1153473","volume":"127","author":"M Cakir","year":"2017","unstructured":"Cakir M, Calikoglu C, Y\u0131lmaz A, Akpinar E, Bayraktutan Z, Topcu A. Serum nesfatin-1 levels: a potential new biomarker in patients with subarachnoid hemorrhage. Int J Neurosci. 2017;127(2):154\u201360. https:\/\/doi.org\/10.3109\/00207454.2016.1153473.","journal-title":"Int J Neurosci"},{"key":"455_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.105837","volume":"194","author":"V Acik","year":"2020","unstructured":"Acik V, Matyar S, Arslan A, \u0130stemen \u0130, Olguner SK, Arslan B, et al. Relationship of spontaneous subarachnoid haemorrhage and cerebral aneurysm to serum visfatin and nesfatin-1 levels. Clin Neurol Neurosurg. 2020;194:105837. https:\/\/doi.org\/10.1016\/j.clineuro.2020.105837.","journal-title":"Clin Neurol Neurosurg"},{"issue":"1\u20132","key":"455_CR176","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.neulet.2006.05.029","volume":"404","author":"K Nyl\u00e9n","year":"2006","unstructured":"Nyl\u00e9n K, Csajbok LZ, Ost M, Rashid A, Karlsson JE, Blennow K, et al. CSF -neurofilament correlates with outcome after aneurysmal subarachnoid hemorrhage. Neurosci Lett. 2006;404(1\u20132):132\u20136. https:\/\/doi.org\/10.1016\/j.neulet.2006.05.029.","journal-title":"Neurosci Lett"},{"key":"455_CR177","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1016\/j.wneu.2018.04.184","volume":"116","author":"H Cai","year":"2018","unstructured":"Cai H, Zheng S, Cai B, Yao P, Ding C, Chen F, et al. Neuroglobin as a novel biomarker for predicting poor outcomes in aneurysmal subarachnoid hemorrhage. World Neurosurg. 2018;116:e258\u201365. https:\/\/doi.org\/10.1016\/j.wneu.2018.04.184.","journal-title":"World Neurosurg"},{"issue":"7","key":"455_CR178","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1179\/016164101101199225","volume":"23","author":"Y Hirashima","year":"2001","unstructured":"Hirashima Y, Endo S, Nakamura S, Kurimoto M, Takaku A. Cerebrospinal fluid membrane-bound tissue factor and myelin basic protein in the course of vasospasm after subarachnoid hemorrhage. Neurol Res. 2001;23(7):715\u201320. https:\/\/doi.org\/10.1179\/016164101101199225.","journal-title":"Neurol Res"},{"issue":"3","key":"455_CR179","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00701-019-04185-9","volume":"162","author":"N W\u0105sik","year":"2020","unstructured":"W\u0105sik N, Sok\u00f3\u0142 B, Ho\u0142ysz M, Ma\u0144ko W, Juszkat R, Jagodzi\u0144ski PP, et al. Serum myelin basic protein as a marker of brain injury in aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien). 2020;162(3):545\u201352. https:\/\/doi.org\/10.1007\/s00701-019-04185-9.","journal-title":"Acta Neurochir (Wien)"},{"issue":"9","key":"455_CR180","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045676","volume":"7","author":"E Mart\u00ednez-Morillo","year":"2012","unstructured":"Mart\u00ednez-Morillo E, Diamandis A, Romaschin AD, Diamandis EP. Kallikrein 6 as a serum prognostic marker in patients with aneurysmal subarachnoid hemorrhage. PLoS ONE. 2012;7(9):e45676. https:\/\/doi.org\/10.1371\/journal.pone.0045676.","journal-title":"PLoS ONE"},{"issue":"1","key":"455_CR181","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/jnnp-2013-307326","volume":"86","author":"R Helbok","year":"2015","unstructured":"Helbok R, Schiefecker A, Delazer M, Beer R, Bodner T, Pfausler B, et al. Cerebral tau is elevated after aneurysmal subarachnoid haemorrhage and associated with brain metabolic distress and poor functional and cognitive long-term outcome. J Neurol Neurosurg Psychiatry. 2015;86(1):79\u201386. https:\/\/doi.org\/10.1136\/jnnp-2013-307326.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"455_CR182","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.2174\/1389450117666160201111804","volume":"18","author":"AJ Schiefecker","year":"2017","unstructured":"Schiefecker AJ, Dietmann A, Beer R, Pfausler B, Lackner P, Kofler M, et al. Neuroinflammation is Associated with Brain Extracellular TAU-Protein Release After Spontaneous Subarachnoid Hemorrhage. Curr Drug Targets. 2017;18(12):1408\u201316. https:\/\/doi.org\/10.2174\/1389450117666160201111804.","journal-title":"Curr Drug Targets"},{"issue":"2","key":"455_CR183","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3171\/jns.2003.99.2.0376","volume":"99","author":"RE Clatterbuck","year":"2003","unstructured":"Clatterbuck RE, Gailloud P, Ogata L, Gebremariam A, Dietsch GN, Murphy KJ, et al. Prevention of cerebral vasospasm by a humanized anti-CD11\/CD18 monoclonal antibody administered after experimental subarachnoid hemorrhage in nonhuman primates. J Neurosurg. 2003;99(2):376\u201382. https:\/\/doi.org\/10.3171\/jns.2003.99.2.0376.","journal-title":"J Neurosurg"},{"key":"455_CR184","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/978-3-7091-1192-5_42","volume":"115","author":"JJ Provencio","year":"2013","unstructured":"Provencio JJ. Inflammation in subarachnoid hemorrhage and delayed deterioration associated with vasospasm: a review. Acta Neurochir Suppl. 2013;115:233\u20138. https:\/\/doi.org\/10.1007\/978-3-7091-1192-5_42.","journal-title":"Acta Neurochir Suppl"},{"key":"455_CR185","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/384342","volume":"2014","author":"BA Miller","year":"2014","unstructured":"Miller BA, Turan N, Chau M, Pradilla G. Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage. Biomed Res Int. 2014;2014:384342. https:\/\/doi.org\/10.1155\/2014\/384342.","journal-title":"Biomed Res Int"},{"issue":"5","key":"455_CR186","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ni.3153","volume":"16","author":"CA Hunter","year":"2015","unstructured":"Hunter CA, Jones SA. Il-6 as a keystone cytokine in health and disease. Nat Immunol. 2015;16(5):448\u201357. https:\/\/doi.org\/10.1038\/ni.3153.","journal-title":"Nat Immunol"},{"key":"455_CR187","doi-asserted-by":"publisher","unstructured":"Chaudhry S R, Stoffel-Wagner B, Kinfe T M, G\u00fcresir E, Vatter H, Dietrich D, et al. Elevated Systemic IL-6 Levels in Patients with Aneurysmal Subarachnoid Hemorrhage Is an Unspecific Marker for Post-SAH Complications. Int J Mol Sci. 2017;18(12). https:\/\/doi.org\/10.3390\/ijms18122580.","DOI":"10.3390\/ijms18122580"},{"issue":"1","key":"455_CR188","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12974-022-02592-x","volume":"19","author":"B Lucke-Wold","year":"2022","unstructured":"Lucke-Wold B, Dodd W, Motwani K, Hosaka K, Laurent D, Martinez M, et al. Investigation and modulation of interleukin-6 following subarachnoid hemorrhage: targeting inflammatory activation for cerebral vasospasm. J Neuroinflammation. 2022;19(1):228. https:\/\/doi.org\/10.1186\/s12974-022-02592-x.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"455_CR189","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1161\/hypertensionaha.108.128124","volume":"54","author":"C Vecchione","year":"2009","unstructured":"Vecchione C, Frati A, Di Pardo A, Cifelli G, Carnevale D, Gentile MT, et al. Tumor necrosis factor-alpha mediates hemolysis-induced vasoconstriction and the cerebral vasospasm evoked by subarachnoid hemorrhage. Hypertension. 2009;54(1):150\u20136. https:\/\/doi.org\/10.1161\/hypertensionaha.108.128124.","journal-title":"Hypertension"},{"issue":"7","key":"455_CR190","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.jocn.2009.11.041","volume":"17","author":"KA Hanafy","year":"2010","unstructured":"Hanafy KA, Stuart RM, Khandji AG, Connolly ES, Badjatia N, Mayer SA, et al. Relationship between brain interstitial fluid tumor necrosis factor-\u03b1 and cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Clin Neurosci. 2010;17(7):853\u20136. https:\/\/doi.org\/10.1016\/j.jocn.2009.11.041.","journal-title":"J Clin Neurosci"},{"key":"455_CR191","doi-asserted-by":"publisher","unstructured":"Li F, Zhang W, Wang M, Jia P. The Effect and Clinical Implications of IL-1\u03b2 on the Development of Aneurysmal Subarachnoid Hemorrhage. Clin Lab. 2024. 70(11). https:\/\/doi.org\/10.7754\/Clin.Lab.2024.240608.","DOI":"10.7754\/Clin.Lab.2024.240608"},{"key":"455_CR192","unstructured":"!!! INVALID CITATION !!! ;"},{"issue":"6","key":"455_CR193","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1161\/01.Str.0000070424.38138.30","volume":"34","author":"H Tsurutani","year":"2003","unstructured":"Tsurutani H, Ohkuma H, Suzuki S. Effects of thrombin inhibitor on thrombin-related signal transduction and cerebral vasospasm in the rabbit subarachnoid hemorrhage model. Stroke. 2003;34(6):1497\u2013500. https:\/\/doi.org\/10.1161\/01.Str.0000070424.38138.30.","journal-title":"Stroke"},{"issue":"3","key":"455_CR194","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.surneu.2005.04.038","volume":"64","author":"CL Lin","year":"2005","unstructured":"Lin CL, Dumont AS, Calisaneller T, Kwan AL, Hwong SL, Lee KS. Monoclonal antibody against E selectin attenuates subarachnoid hemorrhage-induced cerebral vasospasm. Surg Neurol. 2005;64(3):201\u20135. https:\/\/doi.org\/10.1016\/j.surneu.2005.04.038.","journal-title":"Surg Neurol"},{"issue":"5","key":"455_CR195","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s13760-020-01496-y","volume":"121","author":"X Ma","year":"2021","unstructured":"Ma X, Lan F, Zhang Y. Associations between C-reactive protein and white blood cell count, occurrence of delayed cerebral ischemia and poor outcome following aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Acta Neurol Belg. 2021;121(5):1311\u201324. https:\/\/doi.org\/10.1007\/s13760-020-01496-y.","journal-title":"Acta Neurol Belg"},{"issue":"13","key":"455_CR196","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310943","volume":"24","author":"C-Z Chai","year":"2023","unstructured":"Chai C-Z, Ho U-C, Kuo L-T. Systemic inflammation after aneurysmal subarachnoid hemorrhage. Int J Mol Sci. 2023;24(13):10943.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"455_CR197","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12974-022-02564-1","volume":"19","author":"S-H Ahn","year":"2022","unstructured":"Ahn S-H, Burkett A, Paz A, Savarraj JP, Hinds S, Hergenroeder G, et al. Systemic inflammatory markers of persistent cerebral edema after aneurysmal subarachnoid hemorrhage. J Neuroinflammation. 2022;19(1):199. https:\/\/doi.org\/10.1186\/s12974-022-02564-1.","journal-title":"J Neuroinflammation"},{"issue":"12","key":"455_CR198","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1111\/cns.14348","volume":"29","author":"J Zhang","year":"2023","unstructured":"Zhang J, Zhang Z, Wang X, Liu Y, Yu Q, Wang K, et al. Connection between oxidative stress and subcellular organelle in subarachnoid hemorrhage: Novel mechanisms and therapeutic implications. CNS Neurosci Ther. 2023;29(12):3672\u201383. https:\/\/doi.org\/10.1111\/cns.14348.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"455_CR199","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/med.10051","volume":"24","author":"S Gromer","year":"2004","unstructured":"Gromer S, Urig S, Becker K. The thioredoxin system--from science to clinic. Med Res Rev. 2004;24(1):40\u201389. https:\/\/doi.org\/10.1002\/med.10051.","journal-title":"Med Res Rev"},{"key":"455_CR200","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cca.2015.11.030","volume":"453","author":"DS Pan","year":"2016","unstructured":"Pan DS, Le HW, Yan M, Hassan M, Gong JB, Wang H. Change of serum levels of thioredoxin in patients with severe traumatic brain injury. Clin Chim Acta. 2016;453:62\u20136. https:\/\/doi.org\/10.1016\/j.cca.2015.11.030.","journal-title":"Clin Chim Acta"},{"key":"455_CR201","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/152786","volume":"2013","author":"A Pirillo","year":"2013","unstructured":"Pirillo A, Norata GD, Catapano AL. LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm. 2013;2013:152786. https:\/\/doi.org\/10.1155\/2013\/152786.","journal-title":"Mediators Inflamm"},{"issue":"8","key":"455_CR202","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.4103\/1673-5374.332157","volume":"17","author":"HY Zhang","year":"2022","unstructured":"Zhang HY, Lu X, Hao YH, Tang L, He ZY. Oxidized low-density lipoprotein receptor 1: a novel potential therapeutic target for intracerebral hemorrhage. Neural Regen Res. 2022;17(8):1795\u2013801. https:\/\/doi.org\/10.4103\/1673-5374.332157.","journal-title":"Neural Regen Res"},{"issue":"1","key":"455_CR203","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.hest.2020.08.003","volume":"2","author":"AY Chan","year":"2021","unstructured":"Chan AY, Choi EH, Yuki I, Suzuki S, Golshani K, Chen JW, et al. Cerebral vasospasm after subarachnoid hemorrhage: developing treatments. Brain Hemorrhages. 2021;2(1):15\u201323. https:\/\/doi.org\/10.1016\/j.hest.2020.08.003.","journal-title":"Brain Hemorrhages"},{"key":"455_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.wnsx.2023.100205","volume":"19","author":"S Batista","year":"2023","unstructured":"Batista S, Bocanegra-Becerra JE, Claassen B, Rubi\u00e3o F, Rabelo NN, Figueiredo EG, et al. Biomarkers in aneurysmal subarachnoid hemorrhage: a short review. World Neurosurg X. 2023;19:100205. https:\/\/doi.org\/10.1016\/j.wnsx.2023.100205.","journal-title":"World Neurosurg X"},{"issue":"4","key":"455_CR205","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/hypertensionaha.115.06117","volume":"66","author":"F Perticone","year":"2015","unstructured":"Perticone F, Perticone M, Maio R, Sciacqua A, Andreucci M, Tripepi G, et al. Serum alkaline phosphatase negatively affects endothelium-dependent vasodilation in na\u00efve hypertensive patients. Hypertension. 2015;66(4):874\u201380. https:\/\/doi.org\/10.1161\/hypertensionaha.115.06117.","journal-title":"Hypertension"},{"issue":"8","key":"455_CR206","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.numecd.2016.02.003","volume":"26","author":"M Perticone","year":"2016","unstructured":"Perticone M, Maio R, Sciacqua A, Cimellaro A, Andreucci M, Tripepi G, et al. Serum phosphorus levels are associated with endothelial dysfunction in hypertensive patients. Nutr Metab Cardiovasc Dis. 2016;26(8):683\u20138. https:\/\/doi.org\/10.1016\/j.numecd.2016.02.003.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"455_CR207","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.08.041","volume":"27","author":"C Zhong","year":"2018","unstructured":"Zhong C, You S, Chen J, Zhai G, Du H, Luo Y, et al. Serum Alkaline Phosphatase, Phosphate, and In-Hospital Mortality in Acute Ischemic Stroke Patients. J Stroke Cerebrovasc Dis. 2018;27(1):257\u201366. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2017.08.041.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"455_CR208","doi-asserted-by":"publisher","unstructured":"S P, S P K,Jb A. Increased serum alkaline phosphatase and serum phosphate as predictors of mortality after stroke. J Clin Diagn Res. 2014;8(8):Cc01\u20133. https:\/\/doi.org\/10.7860\/jcdr\/2014\/8350.4649.","DOI":"10.7860\/jcdr\/2014\/8350.4649"},{"key":"455_CR209","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2022.107185","volume":"215","author":"A Diosdado","year":"2022","unstructured":"Diosdado A, Ndieugnou Djangang N, Diaferia D, Minini A, Casu GS, Peluso L, et al. Phosphatase alkaline levels are not associated with poor outcomes in subarachnoid hemorrhage patients. Clin Neurol Neurosurg. 2022;215:107185. https:\/\/doi.org\/10.1016\/j.clineuro.2022.107185.","journal-title":"Clin Neurol Neurosurg"},{"issue":"8","key":"455_CR210","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/j.1365-2044.1996.tb07883.x","volume":"51","author":"A Mccluskey","year":"1996","unstructured":"Mccluskey A, Thomas AN, Bowles BJ, Kishen R. The prognostic value of serial measurements of serum albumin concentration in patients admitted to an intensive care unit. Anaesthesia. 1996;51(8):724\u20137. https:\/\/doi.org\/10.1111\/j.1365-2044.1996.tb07883.x.","journal-title":"Anaesthesia"},{"key":"455_CR211","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2021.719226","volume":"8","author":"F Shang","year":"2021","unstructured":"Shang F, Zhao H, Cheng W, Qi M, Wang N, Qu X. Predictive value of the serum albumin level on admission in patients with spontaneous subarachnoid hemorrhage. Front Surg. 2021;8:719226. https:\/\/doi.org\/10.3389\/fsurg.2021.719226.","journal-title":"Front Surg"},{"issue":"1","key":"455_CR212","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2023.107478","volume":"33","author":"G Wu","year":"2024","unstructured":"Wu G, Li S, Luo M, Li X, Zhu X, Zhang J, et al. Role of serum alkaline phosphatase as a potential biomarker of severity and prognosis in intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2024;33(1):107478. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2023.107478.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"3","key":"455_CR213","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3171\/2014.10.Jns132694","volume":"122","author":"BN Jaja","year":"2015","unstructured":"Jaja BN, Lingsma H, Schweizer TA, Thorpe KE, Steyerberg EW, Macdonald RL. Prognostic value of premorbid hypertension and neurological status in aneurysmal subarachnoid hemorrhage: pooled analyses of individual patient data in the SAHIT repository. J Neurosurg. 2015;122(3):644\u201352. https:\/\/doi.org\/10.3171\/2014.10.Jns132694.","journal-title":"J Neurosurg"},{"issue":"1","key":"455_CR214","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s12028-012-9692-2","volume":"18","author":"IACW Tiebosch","year":"2013","unstructured":"Tiebosch IACW, Dijkhuizen RM, Cobelens PM, Bouts MJRJ, Zwartbol R, Van Der Meide PH, et al. Effect of Interferon-\u03b2 on Neuroinflammation, Brain Injury and Neurological Outcome After Experimental Subarachnoid Hemorrhage. Neurocrit Care. 2013;18(1):96\u2013105. https:\/\/doi.org\/10.1007\/s12028-012-9692-2.","journal-title":"Neurocrit Care"},{"issue":"3","key":"455_CR215","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/s1474-4422(22)00009-6","volume":"21","author":"P Benkert","year":"2022","unstructured":"Benkert P, Meier S, Schaedelin S, Manouchehrinia A, Yaldizli \u00d6, Maceski A, et al. Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study. Lancet Neurol. 2022;21(3):246\u201357. https:\/\/doi.org\/10.1016\/s1474-4422(22)00009-6.","journal-title":"Lancet Neurol"},{"issue":"1","key":"455_CR216","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s12035-019-01698-3","volume":"57","author":"Z Alirezaei","year":"2020","unstructured":"Alirezaei Z, Pourhanifeh MH, Borran S, Nejati M, Mirzaei H, Hamblin MR. Neurofilament light chain as a biomarker, and correlation with magnetic resonance imaging in diagnosis of CNS-related disorders. Mol Neurobiol. 2020;57(1):469\u201391. https:\/\/doi.org\/10.1007\/s12035-019-01698-3.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"455_CR217","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/jnnp.2009.177667","volume":"82","author":"ER Zanier","year":"2011","unstructured":"Zanier ER, Refai D, Zipfel GJ, Zoerle T, Longhi L, Esparza TJ, et al. Neurofilament light chain levels in ventricular cerebrospinal fluid after acute aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2011;82(2):157\u20139. https:\/\/doi.org\/10.1136\/jnnp.2009.177667.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"455_CR218","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1016\/j.wneu.2024.06.024","volume":"189","author":"H Labib","year":"2024","unstructured":"Labib H, Tjerkstra MA, Teunissen CE, Horn J, Vermunt L, Coert BA, et al. Plasma neurofilament light chain as a biomarker for poor outcome after aneurysmal subarachnoid hemorrhage. World Neurosurg. 2024;189:e238\u201352. https:\/\/doi.org\/10.1016\/j.wneu.2024.06.024.","journal-title":"World Neurosurg"},{"issue":"6\u20137","key":"455_CR219","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3109\/1354750x.2015.1094138","volume":"20","author":"H Chen","year":"2015","unstructured":"Chen H, Cao HL, Chen SW, Guo Y, Gao WW, Tian HL, et al. Neuroglobin and Nogo-a as biomarkers for the severity and prognosis of traumatic brain injury. Biomarkers. 2015;20(6\u20137):495\u2013501. https:\/\/doi.org\/10.3109\/1354750x.2015.1094138.","journal-title":"Biomarkers"},{"issue":"2","key":"455_CR220","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/glia.20058","volume":"48","author":"R Terayama","year":"2004","unstructured":"Terayama R, Bando Y, Takahashi T, Yoshida S. Differential expression of neuropsin and protease M\/neurosin in oligodendrocytes after injury to the spinal cord. Glia. 2004;48(2):91\u2013101. https:\/\/doi.org\/10.1002\/glia.20058.","journal-title":"Glia"},{"issue":"4","key":"455_CR221","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1021\/bi015781a","volume":"41","author":"SI Blaber","year":"2002","unstructured":"Blaber SI, Scarisbrick IA, Bernett MJ, Dhanarajan P, Seavy MA, Jin Y, et al. Enzymatic properties of rat myelencephalon-specific protease. Biochemistry. 2002;41(4):1165\u201373. https:\/\/doi.org\/10.1021\/bi015781a.","journal-title":"Biochemistry"},{"issue":"2","key":"455_CR222","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s10143-017-0900-6","volume":"41","author":"H Joswig","year":"2018","unstructured":"Joswig H, Korte W, Fr\u00fch S, Epprecht L, Hildebrandt G, Fournier JY, et al. Neurodegenerative cerebrospinal fluid biomarkers tau and amyloid beta predict functional, quality of life, and neuropsychological outcomes after aneurysmal subarachnoid hemorrhage. Neurosurg Rev. 2018;41(2):605\u201314. https:\/\/doi.org\/10.1007\/s10143-017-0900-6.","journal-title":"Neurosurg Rev"},{"key":"455_CR223","doi-asserted-by":"publisher","unstructured":"Gaastra B, Coy L, Zolnourian A, Holton P, Galea I, Skipp P, et al. Proteomic Discovery Study of Cerebrospinal Fluid After Aneurysmal Subarachnoid Hemorrhage. Stroke. 2025. https:\/\/doi.org\/10.1161\/strokeaha.125.051215.","DOI":"10.1161\/strokeaha.125.051215"},{"issue":"2","key":"455_CR224","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/s0090-3019(99)00179-2","volume":"53","author":"K Suzuki","year":"2000","unstructured":"Suzuki K, Meguro K, Sakurai T, Saitoh Y, Takeuchi S, Nose T. Endothelin-1 concentration increases in the cerebrospinal fluid in cerebral vasospasm caused by subarachnoid hemorrhage. Surg Neurol. 2000;53(2):131\u20135. https:\/\/doi.org\/10.1016\/s0090-3019(99)00179-2.","journal-title":"Surg Neurol"},{"issue":"1","key":"455_CR225","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12028-011-9508-9","volume":"15","author":"BP Thampatty","year":"2011","unstructured":"Thampatty BP, Sherwood PR, Gallek MJ, Crago EA, Ren D, Hricik AJ, et al. Role of endothelin-1 in human aneurysmal subarachnoid hemorrhage: associations with vasospasm and delayed cerebral ischemia. Neurocrit Care. 2011;15(1):19\u201327. https:\/\/doi.org\/10.1007\/s12028-011-9508-9.","journal-title":"Neurocrit Care"},{"issue":"6","key":"455_CR226","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3346\/jkms.2001.16.6.774","volume":"16","author":"KY Kwon","year":"2001","unstructured":"Kwon KY, Jeon BC. Cytokine levels in cerebrospinal fluid and delayed ischemic deficits in patients with aneurysmal subarachnoid hemorrhage. J Korean Med Sci. 2001;16(6):774\u201380. https:\/\/doi.org\/10.3346\/jkms.2001.16.6.774.","journal-title":"J Korean Med Sci"},{"issue":"1-2","key":"455_CR227","first-page":"141","volume":"25","author":"S Hendryk","year":"2004","unstructured":"Hendryk S, Jarzab B, Josko J. Increase of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH. Neuro Endocrinol Lett. 2004;25(1\u20132):141\u20137.","journal-title":"Neuro Endocrinol Lett"},{"issue":"5","key":"455_CR228","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1227\/01.Neu.0000255440.21495.80","volume":"60","author":"B Schoch","year":"2007","unstructured":"Schoch B, Regel JP, Wichert M, Gasser T, Volbracht L, Stolke D. Analysis of intrathecal interleukin-6 as a potential predictive factor for vasospasm in subarachnoid hemorrhage. Neurosurgery. 2007;60(5):828\u201336. https:\/\/doi.org\/10.1227\/01.Neu.0000255440.21495.80.","journal-title":"Neurosurgery"},{"issue":"1","key":"455_CR229","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79586-3","volume":"11","author":"S Ridwan","year":"2021","unstructured":"Ridwan S, Grote A, Simon M. Interleukin 6 in cerebrospinal fluid is a biomarker for delayed cerebral ischemia (DCI) related infarctions after aneurysmal subarachnoid hemorrhage. Sci Rep. 2021;11(1):12. https:\/\/doi.org\/10.1038\/s41598-020-79586-3.","journal-title":"Sci Rep"},{"issue":"3","key":"455_CR230","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104558","volume":"29","author":"H Hurth","year":"2020","unstructured":"Hurth H, Birkenhauer U, Steiner J, Schlak D, Hennersdorf F, Ebner FH. Delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage - serum D-dimer and C-reactive protein as early markers. J Stroke Cerebrovasc Dis. 2020;29(3):104558. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2019.104558.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"4","key":"455_CR231","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/00008506-200010000-00001","volume":"12","author":"A Gruber","year":"2000","unstructured":"Gruber A, R\u00f6ssler K, Graninger W, Donner A, Illievich MU, Czech T. Ventricular cerebrospinal fluid and serum concentrations of sTNFR-I, IL-1ra, and IL-6 after aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2000;12(4):297\u2013306. https:\/\/doi.org\/10.1097\/00008506-200010000-00001.","journal-title":"J Neurosurg Anesthesiol"},{"issue":"1","key":"455_CR232","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3171\/2018.8.Jns181839","volume":"132","author":"CY Ding","year":"2020","unstructured":"Ding CY, Cai HP, Ge HL, Yu LH, Lin YX, Kang DZ. Assessment of lipoprotein-associated phospholipase A2 level and its changes in the early stages as predictors of delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2020;132(1):62\u20138. https:\/\/doi.org\/10.3171\/2018.8.Jns181839.","journal-title":"J Neurosurg"},{"key":"455_CR233","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.cca.2019.12.014","volume":"502","author":"L Bian","year":"2020","unstructured":"Bian L, Shen F, Mao LG, Zhou W, Liu Z, Chen GL. Tissue kallikrein: a potential serum biomarker to predict delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. Clin Chim Acta. 2020;502:148\u201352. https:\/\/doi.org\/10.1016\/j.cca.2019.12.014.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"455_CR234","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1547","volume":"10","author":"C Ding","year":"2020","unstructured":"Ding C, Kang D, Chen P, Wang Z, Lin Y, Wang D, et al. Early stage neuroglobin level as a predictor of delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. Brain Behav. 2020;10(3):e01547. https:\/\/doi.org\/10.1002\/brb3.1547.","journal-title":"Brain Behav"},{"issue":"1","key":"455_CR235","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3171\/2014.12.Jns13846","volume":"124","author":"A Ehlert","year":"2016","unstructured":"Ehlert A, Schmidt C, W\u00f6lfer J, Manthei G, Jacobs AH, Br\u00fcning R, et al. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study. J Neurosurg. 2016;124(1):51\u20138. https:\/\/doi.org\/10.3171\/2014.12.Jns13846.","journal-title":"J Neurosurg"},{"issue":"2","key":"455_CR236","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s12028-023-01812-3","volume":"39","author":"A Abdulazim","year":"2023","unstructured":"Abdulazim A, Heilig M, Rinkel G, Etminan N. Diagnosis of delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage and triggers for intervention. Neurocrit Care. 2023;39(2):311\u20139. https:\/\/doi.org\/10.1007\/s12028-023-01812-3.","journal-title":"Neurocrit Care"},{"issue":"6","key":"455_CR237","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1177\/08850666211056568","volume":"37","author":"J Bellapart","year":"2022","unstructured":"Bellapart J, Nasrallah F, Winearls J, Lassig-Smith M, Stuart J, Boots R, et al. Diagnostic Sensitivity of Plasma Endothelin-1 for Cerebral Vasospasm After Subarachnoid Hemorrhage, a Multicentre Double-Blind Study. J Intensive Care Med. 2022;37(6):769\u201375. https:\/\/doi.org\/10.1177\/08850666211056568.","journal-title":"J Intensive Care Med"},{"issue":"9","key":"455_CR238","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2025.108395","volume":"34","author":"J Magid-Bernstein","year":"2025","unstructured":"Magid-Bernstein J, Yan J, Herman AL, He Z, Johnson CW, Beatty H, et al. Early CSF inflammatory markers after aneurysmal subarachnoid hemorrhage and their relationship to disease severity and shunt placement. J Stroke Cerebrovasc Dis. 2025;34(9):108395. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2025.108395.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"455_CR239","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jns.2018.06.021","volume":"394","author":"E Watson","year":"2018","unstructured":"Watson E, Ding D, Khattar NK, Everhart DE, James RF. Neurocognitive outcomes after aneurysmal subarachnoid hemorrhage: identifying inflammatory biomarkers. J Neurol Sci. 2018;394:84\u201393. https:\/\/doi.org\/10.1016\/j.jns.2018.06.021.","journal-title":"J Neurol Sci"},{"issue":"5","key":"455_CR240","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1046\/j.1471-4159.1996.67052013.x","volume":"67","author":"LE Rosengren","year":"1996","unstructured":"Rosengren LE, Karlsson JE, Karlsson JO, Persson LI, Wikkels\u00f8 C. Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J Neurochem. 1996;67(5):2013\u20138. https:\/\/doi.org\/10.1046\/j.1471-4159.1996.67052013.x.","journal-title":"J Neurochem"},{"issue":"1","key":"455_CR241","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12028-023-01713-5","volume":"39","author":"MM Treggiari","year":"2023","unstructured":"Treggiari MM, Rabinstein AA, Busl KM, Caylor MM, Citerio G, Deem S, et al. Guidelines for the Neurocritical Care Management of Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care. 2023;39(1):1\u201328. https:\/\/doi.org\/10.1007\/s12028-023-01713-5.","journal-title":"Neurocrit Care"},{"issue":"4","key":"455_CR242","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1161\/01.STR.0000259661.05525.9a","volume":"38","author":"MJ Vermeulen","year":"2007","unstructured":"Vermeulen MJ, Schull MJ. Missed diagnosis of subarachnoid hemorrhage in the emergency department. Stroke. 2007;38(4):1216\u201321. https:\/\/doi.org\/10.1161\/01.STR.0000259661.05525.9a.","journal-title":"Stroke"},{"issue":"9","key":"455_CR243","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-021-01136-9","volume":"21","author":"ML Osgood","year":"2021","unstructured":"Osgood ML. Aneurysmal subarachnoid hemorrhage: review of the pathophysiology and management strategies. Curr Neurol Neurosci Rep. 2021;21(9):50. https:\/\/doi.org\/10.1007\/s11910-021-01136-9.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"9558","key":"455_CR244","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/s0140-6736(07)60153-6","volume":"369","author":"J Van Gijn","year":"2007","unstructured":"Van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet. 2007;369(9558):306\u201318. https:\/\/doi.org\/10.1016\/s0140-6736(07)60153-6.","journal-title":"Lancet"},{"issue":"2","key":"455_CR245","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/brain\/124.2.249","volume":"124","author":"J Van Gijn","year":"2001","unstructured":"Van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: diagnosis, causes and management. Brain. 2001;124(2):249\u201378. https:\/\/doi.org\/10.1093\/brain\/124.2.249.","journal-title":"Brain"},{"key":"455_CR246","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-3-030-04615-6_4","volume":"127","author":"W Boling","year":"2020","unstructured":"Boling W, Kore L. Subarachnoid Hemorrhage-Related Epilepsy. Acta Neurochir Suppl. 2020;127:21\u20135. https:\/\/doi.org\/10.1007\/978-3-030-04615-6_4.","journal-title":"Acta Neurochir Suppl"},{"issue":"3","key":"455_CR247","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1212\/wnl.0000000000004125","volume":"89","author":"A Harroud","year":"2017","unstructured":"Harroud A, Crepeau AZ. Epilepsy and mortality after aneurysmal subarachnoid hemorrhage. Neurology. 2017;89(3):222\u20133. https:\/\/doi.org\/10.1212\/wnl.0000000000004125.","journal-title":"Neurology"},{"issue":"3","key":"455_CR248","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1161\/strokeaha.115.011386","volume":"47","author":"NM Dubosh","year":"2016","unstructured":"Dubosh NM, Bellolio MF, Rabinstein AA, Edlow JA. Sensitivity of early brain computed tomography to exclude aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Stroke. 2016;47(3):750\u20135. https:\/\/doi.org\/10.1161\/strokeaha.115.011386.","journal-title":"Stroke"},{"issue":"9","key":"455_CR249","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/acem.12984","volume":"23","author":"CR Carpenter","year":"2016","unstructured":"Carpenter CR, Hussain AM, Ward MJ, Zipfel GJ, Fowler S, Pines JM, et al. Spontaneous Subarachnoid Hemorrhage: A Systematic Review and Meta-analysis Describing the Diagnostic Accuracy of History, Physical Examination, Imaging, and Lumbar Puncture With an Exploration of Test Thresholds. Acad Emerg Med. 2016;23(9):963\u20131003. https:\/\/doi.org\/10.1111\/acem.12984.","journal-title":"Acad Emerg Med"},{"issue":"11","key":"455_CR250","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1136\/emermed-2021-211900","volume":"39","author":"M Walton","year":"2022","unstructured":"Walton M, Hodgson R, Eastwood A, Harden M, Storey J, Hassan T, et al. Management of patients presenting to the emergency department with sudden onset severe headache: systematic review of diagnostic accuracy studies. Emerg Med J. 2022;39(11):818\u201325. https:\/\/doi.org\/10.1136\/emermed-2021-211900.","journal-title":"Emerg Med J"},{"issue":"3","key":"455_CR251","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1161\/STROKEAHA.115.011386","volume":"47","author":"NM Dubosh","year":"2016","unstructured":"Dubosh NM, Bellolio MF, Rabinstein AA, Edlow JA. Sensitivity of early brain computed tomography to exclude aneurysmal subarachnoid hemorrhage. Stroke. 2016;47(3):750\u20135. https:\/\/doi.org\/10.1161\/STROKEAHA.115.011386.","journal-title":"Stroke"},{"issue":"2","key":"455_CR252","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1385\/NCC:2:2:110","volume":"2","author":"DS Rosen","year":"2005","unstructured":"Rosen DS, Macdonald RL. Subarachnoid hemorrhage grading scales. Neurocrit Care. 2005;2(2):110\u20138. https:\/\/doi.org\/10.1385\/NCC:2:2:110.","journal-title":"Neurocrit Care"},{"issue":"1","key":"455_CR253","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1227\/00006123-198001000-00001","volume":"6","author":"CM Fisher","year":"1980","unstructured":"Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980;6(1):1\u20139.","journal-title":"Neurosurgery"},{"issue":"6","key":"455_CR254","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1590\/s0004-282x2011000700012","volume":"69","author":"AM Oliveira","year":"2011","unstructured":"Oliveira AM, Paiva WS, Figueiredo EG, Oliveira HA, Teixeira MJ. Fisher revised scale for assessment of prognosis in patients with subarachnoid hemorrhage. Arq Neuropsiquiatr. 2011;69(6):910\u20133. https:\/\/doi.org\/10.1590\/s0004-282x2011000700012.","journal-title":"Arq Neuropsiquiatr"},{"issue":"3","key":"455_CR255","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.diii.2021.10.005","volume":"103","author":"M Soumah","year":"2022","unstructured":"Soumah M, Brami J, Simonato D, Chousterman B, Guillonnet A, Bernat AL, et al. Computed tomography angiography for quantification of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Diagn Interv Imaging. 2022;103(3):161\u20139. https:\/\/doi.org\/10.1016\/j.diii.2021.10.005.","journal-title":"Diagn Interv Imaging"},{"issue":"1121","key":"455_CR256","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20200893","volume":"94","author":"CG Colip","year":"2021","unstructured":"Colip CG, Wo S, Hippe DS, Watase H, Urdaneta-Moncada AR, Zhu C, et al. Computed tomography angiography findings predictive of post-intervention vasospasm in patients with aneurysmal subarachnoid hemorrhage. Br J Radiol. 2021;94(1121):20200893. https:\/\/doi.org\/10.1259\/bjr.20200893.","journal-title":"Br J Radiol"},{"issue":"3","key":"455_CR257","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1177\/000331978103200309","volume":"32","author":"K Dalessandri","year":"1981","unstructured":"Dalessandri K, St John JN, Carson SN. Correction and monitoring of postoperative cerebral vasospasm. Angiology. 1981;32(3):212\u20136. https:\/\/doi.org\/10.1177\/000331978103200309.","journal-title":"Angiology"},{"issue":"6","key":"455_CR258","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","volume":"43","author":"ES Connolly Jr.","year":"2012","unstructured":"Connolly ES Jr., Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/american Stroke Association. Stroke. 2012;43(6):1711\u201337. https:\/\/doi.org\/10.1161\/STR.0b013e3182587839.","journal-title":"Stroke"},{"issue":"5","key":"455_CR259","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3171\/2015.4.Jns15428","volume":"124","author":"G Kumar","year":"2016","unstructured":"Kumar G, Shahripour RB, Harrigan MR. Vasospasm on transcranial Doppler is predictive of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Neurosurg. 2016;124(5):1257\u201364. https:\/\/doi.org\/10.3171\/2015.4.Jns15428.","journal-title":"J Neurosurg"},{"issue":"1","key":"455_CR260","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4103\/joacp.JOACP_192_17","volume":"35","author":"N Samagh","year":"2019","unstructured":"Samagh N, Bhagat H, Jangra K. Monitoring cerebral vasospasm: how much can we rely on transcranial Doppler. J Anaesthesiol Clin Pharmacol. 2019;35(1):12\u20138. https:\/\/doi.org\/10.4103\/joacp.JOACP_192_17.","journal-title":"J Anaesthesiol Clin Pharmacol"},{"issue":"1","key":"455_CR261","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-14-140","volume":"14","author":"J Konczalla","year":"2014","unstructured":"Konczalla J, Platz J, Schuss P, Vatter H, Seifert V, G\u00fcresir E. Non-aneurysmal non-traumatic subarachnoid hemorrhage: patient characteristics, clinical outcome and prognostic factors based on a single-center experience in 125 patients. BMC Neurol. 2014;14(1):140. https:\/\/doi.org\/10.1186\/1471-2377-14-140.","journal-title":"BMC Neurol"},{"issue":"13","key":"455_CR262","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3238\/arztebl.2017.0226","volume":"114","author":"AK Petridis","year":"2017","unstructured":"Petridis AK, Kamp MA, Cornelius JF, Beez T, Beseoglu K, Turowski B, et al. Aneurysmal Subarachnoid Hemorrhage. Dtsch Arztebl Int. 2017;114(13):226\u201336. https:\/\/doi.org\/10.3238\/arztebl.2017.0226.","journal-title":"Dtsch Arztebl Int"},{"issue":"6","key":"455_CR263","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1136\/svn-2023-002546","volume":"9","author":"J Wang","year":"2024","unstructured":"Wang J, Meng JF, Wang S, Zhao JZ, Cao Y. Risk stratification of delayed causative aneurysm detection and long-term outcome in angiographically negative spontaneous subarachnoid haemorrhage. Stroke Vasc Neurol. 2024;9(6):595\u2013603. https:\/\/doi.org\/10.1136\/svn-2023-002546.","journal-title":"Stroke Vasc Neurol"},{"issue":"12","key":"455_CR264","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1161\/01.str.31.12.2971","volume":"31","author":"K Fassbender","year":"2000","unstructured":"Fassbender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, Sch\u00fctt S, et al. Endothelin-1 in subarachnoid hemorrhage: An acute-phase reactant produced by cerebrospinal fluid leukocytes. Stroke. 2000;31(12):2971\u20135. https:\/\/doi.org\/10.1161\/01.str.31.12.2971.","journal-title":"Stroke"},{"issue":"12","key":"455_CR265","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00701-005-0633-0","volume":"147","author":"S K\u00e4stner","year":"2005","unstructured":"K\u00e4stner S, Oertel MF, Scharbrodt W, Krause M, B\u00f6ker DK, Deinsberger W. Endothelin-1 in plasma, cisternal CSF and microdialysate following aneurysmal SAH. Acta Neurochir (Wien). 2005;147(12):1271\u20139. https:\/\/doi.org\/10.1007\/s00701-005-0633-0.","journal-title":"Acta Neurochir (Wien)"},{"issue":"6","key":"455_CR266","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3171\/jns.2002.97.6.1287","volume":"97","author":"S Juvela","year":"2002","unstructured":"Juvela S. Plasma endothelin and big endothelin concentrations and serum endothelin-converting enzyme activity following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2002;97(6):1287\u201393. https:\/\/doi.org\/10.3171\/jns.2002.97.6.1287.","journal-title":"J Neurosurg"},{"key":"455_CR267","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.835597","volume":"13","author":"D Janigro","year":"2022","unstructured":"Janigro D, Mondello S, Posti JP, Unden J. GFAP and S100B: what you always wanted to know and never dared to ask. Front Neurol. 2022;13:835597. https:\/\/doi.org\/10.3389\/fneur.2022.835597.","journal-title":"Front Neurol"},{"issue":"1","key":"455_CR268","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-020-01687-3","volume":"20","author":"S Lee","year":"2020","unstructured":"Lee S, Kim YO, Ryu JA. Clinical usefulness of early serial measurements of C-reactive protein as outcome predictors in patients with subarachnoid hemorrhage. BMC Neurol. 2020;20(1):112. https:\/\/doi.org\/10.1186\/s12883-020-01687-3.","journal-title":"BMC Neurol"},{"issue":"7","key":"455_CR269","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1089\/neu.2006.23.1179","volume":"23","author":"A Petzold","year":"2006","unstructured":"Petzold A, Keir G, Kerr M, Kay A, Kitchen N, Smith M, et al. Early identification of secondary brain damage in subarachnoid hemorrhage: a role for glial fibrillary acidic protein. J Neurotrauma. 2006;23(7):1179\u201384. https:\/\/doi.org\/10.1089\/neu.2006.23.1179.","journal-title":"J Neurotrauma"},{"issue":"3","key":"455_CR270","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","volume":"18","author":"A Abdelhak","year":"2022","unstructured":"Abdelhak A, Foschi M, Abu-Rumeileh S, Yue JK, D\u2019anna L, Huss A, et al. Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Rev Neurol. 2022;18(3):158\u201372. https:\/\/doi.org\/10.1038\/s41582-021-00616-3.","journal-title":"Nat Rev Neurol"},{"key":"455_CR271","doi-asserted-by":"publisher","unstructured":"Cenik Y, Baydin A, \u00c7akmak E, Fidan M, Aydin K, Tuncel \u00d6K, et al. The Effect of Biomarkers and Optic Nerve Sheath Diameter in Determining Mortality in non-Traumatic Subarachnoid Hemorrhage. Clini Neurol Neurosurg. 2021;207:106813. https:\/\/doi.org\/10.1016\/j.clineuro.2021.106813.","DOI":"10.1016\/j.clineuro.2021.106813"},{"issue":"4","key":"455_CR272","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13040940","volume":"13","author":"K Li","year":"2024","unstructured":"Li K, Khan D, Fischer I, H\u00e4nggi D, Cornelius JF, Muhammad S. CLR (C-reactive protein to lymphocyte ratio) served as a promising predictive biomarker for cerebral vasospasm in aneurysmal subarachnoid hemorrhage (aSAH): a retrospective cohort study. J Clin Med. 2024;13(4):940.","journal-title":"J Clin Med"},{"issue":"3","key":"455_CR273","doi-asserted-by":"publisher","first-page":"647","DOI":"10.14336\/ad.2021.1121","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu Y, Zheng Y, Wang T, Jiao L, Luo Y. VEGF, a key factor for blood brain barrier injury after cerebral ischemic stroke. Aging Dis. 2022;13(3):647\u201354. https:\/\/doi.org\/10.14336\/ad.2021.1121.","journal-title":"Aging Dis"},{"issue":"4","key":"455_CR274","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nrclinonc.2009.14","volume":"6","author":"ER Gerstner","year":"2009","unstructured":"Gerstner ER, Duda DG, Di Tomaso E, Ryg PA, Loeffler JS, Sorensen AG, et al. VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer. Nat Rev Clin Oncol. 2009;6(4):229\u201336. https:\/\/doi.org\/10.1038\/nrclinonc.2009.14.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"455_CR275","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40644-019-0256-y","volume":"19","author":"Z Sun","year":"2019","unstructured":"Sun Z, Li Y, Wang Y, Fan X, Xu K, Wang K, et al. Radiogenomic analysis of vascular endothelial growth factor in patients with diffuse gliomas. Cancer Imaging. 2019;19(1):68. https:\/\/doi.org\/10.1186\/s40644-019-0256-y.","journal-title":"Cancer Imaging"},{"key":"455_CR276","doi-asserted-by":"publisher","unstructured":"Deng X, Liu M, Sun J, Li M, Liu D, Li L, et al. Feasibility of MRI-based radiomics features for predicting lymph node metastases and VEGF expression in cervical cancer. Eur J Radiol. 2021;134(109429. https:\/\/doi.org\/10.1016\/j.ejrad.2020.109429.","DOI":"10.1016\/j.ejrad.2020.109429"},{"issue":"4","key":"455_CR277","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00062-021-01015-3","volume":"31","author":"VC Keil","year":"2021","unstructured":"Keil VC, Gielen GH, Pintea B, Baumgarten P, Datsi A, Hittatiya K, et al. DCE-MRI in Glioma, Infiltration Zone and Healthy Brain to Assess Angiogenesis: A Biopsy Study. Clin Neuroradiol. 2021;31(4):1049\u201358. https:\/\/doi.org\/10.1007\/s00062-021-01015-3.","journal-title":"Clin Neuroradiol"},{"issue":"3","key":"455_CR278","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3174\/ajnr.A5897","volume":"40","author":"PH Hackett","year":"2019","unstructured":"Hackett PH, Yarnell PR, Weiland DA, Reynard KB. Acute and evolving MRI of high-altitude cerebral edema: microbleeds, edema, and pathophysiology. AJNR Am J Neuroradiol. 2019;40(3):464\u20139. https:\/\/doi.org\/10.3174\/ajnr.A5897.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"9","key":"455_CR279","first-page":"787","volume":"50","author":"BC Chu","year":"1998","unstructured":"Chu BC, Miyasaka K. [The clinical application of diffusion weighted magnetic resonance imaging to acute cerebrovascular disorders]. No To Shinkei. 1998;50(9):787\u201395.","journal-title":"No To Shinkei"},{"issue":"6","key":"455_CR280","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1177\/0271678x18768670","volume":"38","author":"JJ Russin","year":"2018","unstructured":"Russin JJ, Montagne A, D\u2019amore F, He S, Shiroishi MS, Rennert RC, et al. Permeability imaging as a predictor of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2018;38(6):973\u20139. https:\/\/doi.org\/10.1177\/0271678x18768670.","journal-title":"J Cereb Blood Flow Metab"},{"key":"455_CR281","doi-asserted-by":"publisher","first-page":"e743","DOI":"10.1016\/j.wneu.2019.06.213","volume":"130","author":"D Starnoni","year":"2019","unstructured":"Starnoni D, Maduri R, Hajdu SD, Pierzchala K, Giammattei L, Rocca A, et al. Early perfusion computed tomography scan for prediction of vasospasm and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. World Neurosurg. 2019;130:e743\u201352. https:\/\/doi.org\/10.1016\/j.wneu.2019.06.213.","journal-title":"World Neurosurg"},{"key":"455_CR282","doi-asserted-by":"publisher","unstructured":"Robba C, Busl KM, Claassen J, Diringer M N, Helbok R, Park S, et al. Contemporary management of aneurysmal subarachnoid haemorrhage. An update for the intensivist. Intensive Care Med. 2024;50(5):646\u2013664. https:\/\/doi.org\/10.1007\/s00134-024-07387-7.","DOI":"10.1007\/s00134-024-07387-7"},{"issue":"3","key":"455_CR283","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000209690","volume":"103","author":"JD Burns","year":"2024","unstructured":"Burns JD, Lerner DP. Delayed cerebral infarction after aneurysmal subarachnoid hemorrhage: still more questions than answers. Neurology. 2024;103(3):e209690. https:\/\/doi.org\/10.1212\/wnl.0000000000209690.","journal-title":"Neurology"},{"issue":"10","key":"455_CR284","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/strokeaha.110.589275","volume":"41","author":"MD Vergouwen","year":"2010","unstructured":"Vergouwen MD, Vermeulen M, Van Gijn J, Rinkel GJ, Wijdicks EF, Muizelaar JP, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41(10):2391\u20135. https:\/\/doi.org\/10.1161\/strokeaha.110.589275.","journal-title":"Stroke"},{"issue":"7","key":"455_CR285","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1161\/STR.0000000000000436","volume":"54","author":"BL Hoh","year":"2023","unstructured":"Hoh BL, Ko NU, Amin-Hanjani S, Chou SH-Y, Cruz-Flores S, Dangayach NS, et al. 2023 guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association\/American Stroke Association. Stroke. 2023;54(7):e314\u201370.","journal-title":"Stroke"},{"issue":"1","key":"455_CR286","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s42466-025-00407-x","volume":"7","author":"R Kollmar","year":"2025","unstructured":"Kollmar R, Huttner HB, Ozpeynirci Y, Herweh C, Sembill JA, Gerner S, et al. Acute care of aneurysmal subarachnoid hemorrhage: practical consensus statement from a multidisciplinary group of German-speaking neurointensivists and neuroradiologists on behalf of the DIVI neurology section. Neurological Research and Practice. 2025;7(1):54. https:\/\/doi.org\/10.1186\/s42466-025-00407-x.","journal-title":"Neurological Research and Practice"},{"issue":"2","key":"455_CR287","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s10143-021-01704-0","volume":"45","author":"W Zhu","year":"2022","unstructured":"Zhu W, Ling X, Petersen JD, Liu J, Xiao A, Huang J. Clipping versus coiling for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of prospective studies. Neurosurg Rev. 2022;45(2):1291\u2013302. https:\/\/doi.org\/10.1007\/s10143-021-01704-0.","journal-title":"Neurosurg Rev"},{"key":"455_CR288","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-3-319-04981-6_36","volume":"120","author":"HJ Steiger","year":"2015","unstructured":"Steiger HJ, Beez T, Beseoglu K, H\u00e4nggi D, Kamp MA. Perioperative measures to improve outcome after subarachnoid hemorrhage-revisiting the concept of secondary brain injury. Acta Neurochir Suppl. 2015;120:211\u20136. https:\/\/doi.org\/10.1007\/978-3-319-04981-6_36.","journal-title":"Acta Neurochir Suppl"},{"key":"455_CR289","doi-asserted-by":"publisher","unstructured":"Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, Van Den Bergh WM, Vermeulen M, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007;2007(3):Cd000277. https:\/\/doi.org\/10.1002\/14651858.CD000277.pub3.","DOI":"10.1002\/14651858.CD000277.pub3"},{"key":"455_CR290","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176718","volume":"977","author":"R Frank","year":"2024","unstructured":"Frank R, Szarvas PA, Pesti I, Zsigmond A, Berkecz R, Menyh\u00e1rt \u00c1, et al. Nimodipine inhibits spreading depolarization, ischemic injury, and neuroinflammation in mouse live brain slice preparations. Eur J Pharmacol. 2024;977:176718. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176718.","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"455_CR291","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1161\/strokeaha.123.043976","volume":"54","author":"J Schwarting","year":"2023","unstructured":"Schwarting J, Harapan BN, Lin X, Plesnila N, Terpolilli NA. Nimodipine reduces microvasospasms after experimental subarachnoid hemorrhage. Stroke. 2023;54(10):2666\u201370. https:\/\/doi.org\/10.1161\/strokeaha.123.043976.","journal-title":"Stroke"},{"issue":"3","key":"455_CR292","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3171\/2017.5.Jns17831","volume":"129","author":"Y Nagahama","year":"2018","unstructured":"Nagahama Y, Allan L, Nakagawa D, Zanaty M, Starke RM, Chalouhi N, et al. Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia. J Neurosurg. 2018;129(3):702\u201310. https:\/\/doi.org\/10.3171\/2017.5.Jns17831.","journal-title":"J Neurosurg"},{"issue":"6","key":"455_CR293","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/neuros\/nyy550","volume":"85","author":"M Darkwah Oppong","year":"2019","unstructured":"Darkwah Oppong M, Gembruch O, Pierscianek D, K\u00f6hrmann M, Kleinschnitz C, Deuschl C, et al. Post-treatment Antiplatelet Therapy Reduces Risk for Delayed Cerebral Ischemia due to Aneurysmal Subarachnoid Hemorrhage. Neurosurgery. 2019;85(6):827\u201333. https:\/\/doi.org\/10.1093\/neuros\/nyy550.","journal-title":"Neurosurgery"},{"issue":"1","key":"455_CR294","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10143-023-02120-2","volume":"46","author":"KS Lee","year":"2023","unstructured":"Lee KS, Lee C, Dhillon PS, Kirollos R, Nga VDW, Yeo TT, et al. Antiplatelet therapy in aneurysmal subarachnoid hemorrhage: an updated meta-analysis. Neurosurg Rev. 2023;46(1):221. https:\/\/doi.org\/10.1007\/s10143-023-02120-2.","journal-title":"Neurosurg Rev"},{"issue":"4","key":"455_CR295","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s40265-015-0364-3","volume":"75","author":"KC Rogers","year":"2015","unstructured":"Rogers KC, Oliphant CS, Finks SW. Clinical efficacy and safety of cilostazol: a critical review of the literature. Drugs. 2015;75(4):377\u201395. https:\/\/doi.org\/10.1007\/s40265-015-0364-3.","journal-title":"Drugs"},{"issue":"12","key":"455_CR296","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1097\/01.Wcb.0000143536.22131.D7","volume":"24","author":"S Birk","year":"2004","unstructured":"Birk S, Kruuse C, Petersen KA, Jonassen O, Tfelt-Hansen P, Olesen J. The phosphodiesterase 3 inhibitor cilostazol dilates large cerebral arteries in humans without affecting regional cerebral blood flow. J Cereb Blood Flow Metab. 2004;24(12):1352\u20138. https:\/\/doi.org\/10.1097\/01.Wcb.0000143536.22131.D7.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"455_CR297","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1007\/s10787-023-01361-3","volume":"31","author":"A Soltani","year":"2023","unstructured":"Soltani A, Chugaeva UY, Ramadan MF, Saleh EAM, Al-Hasnawi SS, Romero-Parra RM, et al. A narrative review of the effects of dexamethasone on traumatic brain injury in clinical and animal studies: focusing on inflammation. Inflammopharmacology. 2023;31(6):2955\u201371. https:\/\/doi.org\/10.1007\/s10787-023-01361-3.","journal-title":"Inflammopharmacology"},{"issue":"6","key":"455_CR298","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.12669\/pjms.39.6.6768","volume":"39","author":"N Tian","year":"2023","unstructured":"Tian N, Gan N, Song C, Su F, Xie J, Zhang Y. Effects of butylphthalide combined with fasudil on inflammatory factors, cognitive function and vascular endothelial function in patients with subarachnoid hemorrhage complicated with cerebral vasospasm. Pak J Med Sci. 2023;39(6):1737\u201341. https:\/\/doi.org\/10.12669\/pjms.39.6.6768.","journal-title":"Pak J Med Sci"},{"key":"455_CR299","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117487","volume":"548","author":"V Singh","year":"2023","unstructured":"Singh V, Kaur R, Kumari P, Pasricha C, Singh R. ICAM-1 and VCAM-1: gatekeepers in various inflammatory and cardiovascular disorders. Clin Chim Acta. 2023;548:117487. https:\/\/doi.org\/10.1016\/j.cca.2023.117487.","journal-title":"Clin Chim Acta"},{"key":"455_CR300","doi-asserted-by":"publisher","unstructured":"Kosowski M, Smolarczyk-Kosowska J, Hachu\u0142a M, Malig\u0142\u00f3wka M, Basiak M, Machnik G, et al. The Effects of Statins on Neurotransmission and Their Neuroprotective Role in Neurological and Psychiatric Disorders. Molecules. 2021;26(10). https:\/\/doi.org\/10.3390\/molecules26102838.","DOI":"10.3390\/molecules26102838"},{"issue":"8","key":"455_CR301","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1212\/01.wnl.0000120550.00643.dc","volume":"62","author":"PE Vos","year":"2004","unstructured":"Vos PE, Lamers KJ, Hendriks JC, Van Haaren M, Beems T, Zimmerman C, et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology. 2004;62(8):1303\u201310. https:\/\/doi.org\/10.1212\/01.wnl.0000120550.00643.dc.","journal-title":"Neurology"},{"issue":"9","key":"455_CR302","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1136\/jnnp.2009.197244","volume":"82","author":"T Nakura","year":"2011","unstructured":"Nakura T, Osuka K, Inukai T, Takagi T, Takayasu M. Soluble gp130 regulatess interleukin-6 in cerebrospinal fluid after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2011;82(9):952\u20134. https:\/\/doi.org\/10.1136\/jnnp.2009.197244.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"455_CR303","doi-asserted-by":"publisher","unstructured":"Singh N, Hopkins SJ, Hulme S, Galea JP, Hoadley M, Vail A, et al. The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial. J Neuroinflammation. 2014;11:1. https:\/\/doi.org\/10.1186\/1742-2094-11-1.","DOI":"10.1186\/1742-2094-11-1"},{"issue":"2","key":"455_CR304","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3171\/2016.9.Jns16615","volume":"128","author":"J Galea","year":"2018","unstructured":"Galea J, Ogungbenro K, Hulme S, Patel H, Scarth S, Hoadley M, et al. Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) study. J Neurosurg. 2018;128(2):515\u201323. https:\/\/doi.org\/10.3171\/2016.9.Jns16615.","journal-title":"J Neurosurg"},{"issue":"5","key":"455_CR305","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jocn.2012.09.012","volume":"20","author":"YX Pan","year":"2013","unstructured":"Pan YX, Chen KF, Lin YX, Wu W, Zhou XM, Zhang XS, et al. Intracisternal administration of SB203580, a p38 mitogen-activated protein kinase inhibitor, attenuates cerebral vasospasm via inhibition of tumor-necrosis factor-\u03b1. J Clin Neurosci. 2013;20(5):726\u201330. https:\/\/doi.org\/10.1016\/j.jocn.2012.09.012.","journal-title":"J Clin Neurosci"},{"issue":"Pt A","key":"455_CR306","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111106","volume":"125","author":"Q Tian","year":"2023","unstructured":"Tian Q, Li Y, Feng S, Liu C, Guo Y, Wang G, et al. Inhibition of CCR1 attenuates neuroinflammation via the JAK2\/STAT3 signaling pathway after subarachnoid hemorrhage. Int Immunopharmacol. 2023;125(Pt A):111106. https:\/\/doi.org\/10.1016\/j.intimp.2023.111106.","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"455_CR307","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.790","volume":"7","author":"J Cai","year":"2017","unstructured":"Cai J, Xu D, Bai X, Pan R, Wang B, Sun S, et al. Curcumin mitigates cerebral vasospasm and early brain injury following subarachnoid hemorrhage via inhibiting cerebral inflammation. Brain Behav. 2017;7(9):e00790. https:\/\/doi.org\/10.1002\/brb3.790.","journal-title":"Brain Behav"},{"key":"455_CR308","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.brainresbull.2019.01.027","volume":"146","author":"Y Luo","year":"2019","unstructured":"Luo Y, Lu J, Ruan W, Guo X, Chen S. MCC950 attenuated early brain injury by suppressing NLRP3 inflammasome after experimental SAH in rats. Brain Res Bull. 2019;146:320\u20136. https:\/\/doi.org\/10.1016\/j.brainresbull.2019.01.027.","journal-title":"Brain Res Bull"},{"issue":"1","key":"455_CR309","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02207-x","volume":"18","author":"WS Dodd","year":"2021","unstructured":"Dodd WS, Noda I, Martinez M, Hosaka K, Hoh BL. NLRP3 inhibition attenuates early brain injury and delayed cerebral vasospasm after subarachnoid hemorrhage. J Neuroinflammation. 2021;18(1):163. https:\/\/doi.org\/10.1186\/s12974-021-02207-x.","journal-title":"J Neuroinflammation"},{"key":"455_CR310","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1159958","volume":"14","author":"D Xia","year":"2023","unstructured":"Xia D, Yuan J, Wu D, Dai H, Zhuang Z. Salvianolic acid B ameliorates neuroinflammation and neuronal injury via blocking NLRP3 inflammasome and promoting SIRT1 in experimental subarachnoid hemorrhage. Front Immunol. 2023;14:1159958. https:\/\/doi.org\/10.3389\/fimmu.2023.1159958.","journal-title":"Front Immunol"},{"key":"455_CR311","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134654","volume":"717","author":"R Shen","year":"2020","unstructured":"Shen R, Zhou J, Li G, Chen W, Zhong W, Chen Z. SS31 attenuates oxidative stress and neuronal apoptosis in early brain injury following subarachnoid hemorrhage possibly by the mitochondrial pathway. Neurosci Lett. 2020;717:134654. https:\/\/doi.org\/10.1016\/j.neulet.2019.134654.","journal-title":"Neurosci Lett"},{"issue":"4","key":"455_CR312","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1161\/strokeaha.118.021590","volume":"50","author":"T Zhang","year":"2019","unstructured":"Zhang T, Wu P, Budbazar E, Zhu Q, Sun C, Mo J, et al. Mitophagy Reduces Oxidative Stress Via Keap1 (Kelch-Like Epichlorohydrin-Associated Protein 1)\/Nrf2 (Nuclear Factor-E2-Related Factor 2)\/PHB2 (Prohibitin 2) Pathway After Subarachnoid Hemorrhage in Rats. Stroke. 2019;50(4):978\u201388. https:\/\/doi.org\/10.1161\/strokeaha.118.021590.","journal-title":"Stroke"},{"issue":"10","key":"455_CR313","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240122","volume":"15","author":"TH Tsai","year":"2020","unstructured":"Tsai TH, Lin SH, Wu CH, Tsai YC, Yang SF, Lin CL. Mechanisms and therapeutic implications of RTA 408, an activator of Nrf2, in subarachnoid hemorrhage-induced delayed cerebral vasospasm and secondary brain injury. PLoS ONE. 2020;15(10):e0240122. https:\/\/doi.org\/10.1371\/journal.pone.0240122.","journal-title":"PLoS ONE"},{"issue":"6","key":"455_CR314","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3171\/jns.2000.93.6.0992","volume":"93","author":"MD Shaw","year":"2000","unstructured":"Shaw MD, Vermeulen M, Murray GD, Pickard JD, Bell BA, Teasdale GM. Efficacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK\/Netherlands\/Eire TAK-044 Subarachnoid Haemorrhage Study Group. J Neurosurg. 2000;93(6):992\u20137. https:\/\/doi.org\/10.3171\/jns.2000.93.6.0992.","journal-title":"J Neurosurg"},{"issue":"1","key":"455_CR315","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3171\/jns.2005.103.1.0009","volume":"103","author":"P Vajkoczy","year":"2005","unstructured":"Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thome C, Ringel F, et al. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg. 2005;103(1):9\u201317. https:\/\/doi.org\/10.3171\/jns.2005.103.1.0009.","journal-title":"J Neurosurg"},{"issue":"7","key":"455_CR316","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/s1474-4422(11)70108-9","volume":"10","author":"RL Macdonald","year":"2011","unstructured":"Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 2011;10(7):618\u201325. https:\/\/doi.org\/10.1016\/s1474-4422(11)70108-9.","journal-title":"Lancet Neurol"},{"issue":"1","key":"455_CR317","first-page":"14","volume":"42","author":"Z Wang","year":"2012","unstructured":"Wang Z, Fang Q, Dang BQ, Shen XM, Shu Z, Zuo G, et al. Potential contribution of matrix metalloproteinase-9 (mmp-9) to cerebral vasospasm after experimental subarachnoid hemorrhage in rats. Ann Clin Lab Sci. 2012;42(1):14\u201320.","journal-title":"Ann Clin Lab Sci"},{"issue":"7","key":"455_CR318","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1111\/jth.14136","volume":"16","author":"H Wan","year":"2018","unstructured":"Wan H, Wang Y, Ai J, Brathwaite S, Ni H, Macdonald RL, et al. Role of von Willebrand factor and ADAMTS-13 in early brain injury after experimental subarachnoid hemorrhage. J Thromb Haemost. 2018;16(7):1413\u201322. https:\/\/doi.org\/10.1111\/jth.14136.","journal-title":"J Thromb Haemost"},{"key":"455_CR319","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1016\/j.wneu.2020.03.151","volume":"139","author":"UD Akturk","year":"2020","unstructured":"Akturk UD, Tuncer C, Bozkurt H, Sahin OS, Bulut H, Arikok A, et al. Blocking VEGF by bevacizumab attenuates VEGF-induced vasospasm after experimental subarachnoid hemorrhage in rabbits. World Neurosurg. 2020;139:e136\u201343. https:\/\/doi.org\/10.1016\/j.wneu.2020.03.151.","journal-title":"World Neurosurg"},{"issue":"3","key":"455_CR320","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1161\/strokeaha.111.633958","volume":"43","author":"JI Suarez","year":"2012","unstructured":"Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, et al. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683\u201390. https:\/\/doi.org\/10.1161\/strokeaha.111.633958.","journal-title":"Stroke"},{"key":"455_CR321","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neuroscience.2016.12.033","volume":"344","author":"L Wang","year":"2017","unstructured":"Wang L, Li M, Xie Y, Xu L, Ye R, Liu X. Preclinical efficacy of human albumin in subarachnoid hemorrhage. Neuroscience. 2017;344:255\u201364. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.12.033.","journal-title":"Neuroscience"},{"issue":"6","key":"455_CR322","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1227\/NEU.0b013e318210f258","volume":"68","author":"D \u00d6zsavc\u00ed","year":"2011","unstructured":"\u00d6zsavc\u00ed D, Er\u015fahin M, \u015eener A, \u00d6zakpinar \u00d6B, Toklu HZ, Akak\u00edn D, et al. The novel function of nesfatin-1 as an anti-inflammatory and antiapoptotic peptide in subarachnoid hemorrhage-induced oxidative brain damage in rats. Neurosurgery. 2011;68(6):1699\u2013708. https:\/\/doi.org\/10.1227\/NEU.0b013e318210f258.","journal-title":"Neurosurgery"},{"issue":"1","key":"455_CR323","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.peptides.2012.04.014","volume":"36","author":"CH Tang","year":"2012","unstructured":"Tang CH, Fu XJ, Xu XL, Wei XJ, Pan HS. The anti-inflammatory and anti-apoptotic effects of nesfatin-1 in the traumatic rat brain. Peptides. 2012;36(1):39\u201345. https:\/\/doi.org\/10.1016\/j.peptides.2012.04.014.","journal-title":"Peptides"},{"issue":"1","key":"455_CR324","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12974-020-01946-7","volume":"17","author":"M Liu","year":"2020","unstructured":"Liu M, Xu Z, Wang L, Zhang L, Liu Y, Cao J, et al. Cottonseed oil alleviates ischemic stroke injury by inhibiting the inflammatory activation of microglia and astrocyte. J Neuroinflammation. 2020;17(1):270. https:\/\/doi.org\/10.1186\/s12974-020-01946-7.","journal-title":"J Neuroinflammation"},{"key":"455_CR325","doi-asserted-by":"publisher","unstructured":"Chai CZ, Ho UC, Kuo LT. Systemic Inflammation after Aneurysmal Subarachnoid Hemorrhage. Int J Mol Sci. 2023;24(13). https:\/\/doi.org\/10.3390\/ijms241310943.","DOI":"10.3390\/ijms241310943"},{"issue":"5","key":"455_CR326","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1042\/bst0351122","volume":"35","author":"A Simi","year":"2007","unstructured":"Simi A, Tsakiri N, Wang P, Rothwell NJ. Interleukin-1 and inflammatory neurodegeneration. Biochem Soc Trans. 2007;35(5):1122\u20136. https:\/\/doi.org\/10.1042\/bst0351122.","journal-title":"Biochem Soc Trans"},{"key":"455_CR327","doi-asserted-by":"publisher","unstructured":"Zhang Q, Zhang J,Mo J. Pharmacological Modulations of Nrf2 and Therapeutic Implications in Aneurysmal Subarachnoid Hemorrhage. Molecules. 2023;28(4). https:\/\/doi.org\/10.3390\/molecules28041747.","DOI":"10.3390\/molecules28041747"},{"key":"455_CR328","doi-asserted-by":"publisher","unstructured":"Han Y, Zhang T, Su J, Zhao Y, Chenchen, Wang, et al. Apigenin attenuates oxidative stress and neuronal apoptosis in early brain injury following subarachnoid hemorrhage. J Clin Neurosci. 2017;40(157\u2013162. https:\/\/doi.org\/10.1016\/j.jocn.2017.03.003.","DOI":"10.1016\/j.jocn.2017.03.003"},{"key":"455_CR329","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-3-319-04981-6_7","volume":"120","author":"S Chen","year":"2015","unstructured":"Chen S, Wu H, Tang J, Zhang J, Zhang JH. Neurovascular events after subarachnoid hemorrhage: focusing on subcellular organelles. Acta Neurochir Suppl. 2015;120:39\u201346. https:\/\/doi.org\/10.1007\/978-3-319-04981-6_7.","journal-title":"Acta Neurochir Suppl"},{"issue":"10","key":"455_CR330","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1161\/strokeaha.109.560243","volume":"40","author":"A Kramer","year":"2009","unstructured":"Kramer A, Fletcher J. Do endothelin-receptor antagonists prevent delayed neurological deficits and poor outcomes after aneurysmal subarachnoid hemorrhage? A meta-analysis. Stroke. 2009;40(10):3403\u20136. https:\/\/doi.org\/10.1161\/strokeaha.109.560243.","journal-title":"Stroke"},{"issue":"5","key":"455_CR331","doi-asserted-by":"publisher","DOI":"10.1186\/cc11686","volume":"16","author":"J Ma","year":"2012","unstructured":"Ma J, Huang S, Ma L, Liu Y, Li H, You C. Endothelin-receptor antagonists for aneurysmal subarachnoid hemorrhage: an updated meta-analysis of randomized controlled trials. Crit Care. 2012;16(5):R198. https:\/\/doi.org\/10.1186\/cc11686.","journal-title":"Crit Care"},{"issue":"1","key":"455_CR332","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11064-023-04037-0","volume":"49","author":"S Zhou","year":"2024","unstructured":"Zhou S, Nao J. Nesfatin-1: a biomarker and potential therapeutic target in neurological disorders. Neurochem Res. 2024;49(1):38\u201351. https:\/\/doi.org\/10.1007\/s11064-023-04037-0.","journal-title":"Neurochem Res"},{"issue":"11","key":"455_CR333","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1016\/j.peptides.2007.09.005","volume":"28","author":"W Pan","year":"2007","unstructured":"Pan W, Hsuchou H, Kastin AJ. Nesfatin-1 crosses the blood-brain barrier without saturation. Peptides. 2007;28(11):2223\u20138. https:\/\/doi.org\/10.1016\/j.peptides.2007.09.005.","journal-title":"Peptides"},{"issue":"2","key":"455_CR334","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1385\/ncc:2:2:110","volume":"2","author":"DS Rosen","year":"2005","unstructured":"Rosen DS, Macdonald RL. Subarachnoid hemorrhage grading scales: a systematic review. Neurocrit Care. 2005;2(2):110\u20138. https:\/\/doi.org\/10.1385\/ncc:2:2:110.","journal-title":"Neurocrit Care"},{"issue":"1","key":"455_CR335","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1227\/01.neu.0000243277.86222.6c","volume":"59","author":"JA Frontera","year":"2006","unstructured":"Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R, Connolly ES Jr., et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery. 2006;59(1):21\u20137. https:\/\/doi.org\/10.1227\/01.neu.0000243277.86222.6c.","journal-title":"Neurosurgery"},{"issue":"1","key":"455_CR336","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s10143-025-03678-9","volume":"48","author":"MM Khan","year":"2025","unstructured":"Khan MM, Chowdhury AT, Sumon MSI, Maheboob SN, Ali A, Thabet AN, et al. Multi-class subarachnoid hemorrhage severity prediction: addressing challenges in predicting rare outcomes. Neurosurg Rev. 2025;48(1):554. https:\/\/doi.org\/10.1007\/s10143-025-03678-9.","journal-title":"Neurosurg Rev"},{"issue":"2","key":"455_CR337","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1161\/strokeaha.121.035187","volume":"53","author":"CCM Zuurbier","year":"2022","unstructured":"Zuurbier CCM, Molenberg R, Mensing LA, Wermer MJH, Juvela S, Lindgren AE, et al. Sex difference and rupture rate of intracranial aneurysms: an individual patient data meta-analysis. Stroke. 2022;53(2):362\u20139. https:\/\/doi.org\/10.1161\/strokeaha.121.035187.","journal-title":"Stroke"},{"issue":"20","key":"455_CR338","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1212\/WNL.0b013e3181fd62d2","volume":"75","author":"PE Vos","year":"2010","unstructured":"Vos PE, Jacobs B, Andriessen TM, Lamers KJ, Borm GF, Beems T, et al. GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study. Neurology. 2010;75(20):1786\u201393. https:\/\/doi.org\/10.1212\/WNL.0b013e3181fd62d2.","journal-title":"Neurology"},{"issue":"1","key":"455_CR339","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/TA.0b013e3181bbd485","volume":"69","author":"M Honda","year":"2010","unstructured":"Honda M, Tsuruta R, Kaneko T, Kasaoka S, Yagi T, Todani M, et al. Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase. J Trauma. 2010;69(1):104\u20139. https:\/\/doi.org\/10.1097\/TA.0b013e3181bbd485.","journal-title":"J Trauma"},{"issue":"9","key":"455_CR340","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/s1474-4422(22)00256-3","volume":"21","author":"FK Korley","year":"2022","unstructured":"Korley FK, Jain S, Sun X, Puccio AM, Yue JK, Gardner RC, et al. Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study. Lancet Neurol. 2022;21(9):803\u201313. https:\/\/doi.org\/10.1016\/s1474-4422(22)00256-3.","journal-title":"Lancet Neurol"},{"key":"455_CR341","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jns.2015.12.046","volume":"361","author":"H Kiiski","year":"2016","unstructured":"Kiiski H, Tenhunen J, Ala-Peijari M, Huhtala H, H\u00e4m\u00e4l\u00e4inen M, L\u00e5ngsj\u00f6 J, et al. Increased plasma UCH-L1 after aneurysmal subarachnoid hemorrhage is associated with unfavorable neurological outcome. J Neurol Sci. 2016;361:144\u20139. https:\/\/doi.org\/10.1016\/j.jns.2015.12.046.","journal-title":"J Neurol Sci"},{"issue":"1-2","key":"455_CR342","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jim.2004.11.015","volume":"296","author":"WJ Van Geel","year":"2005","unstructured":"Van Geel WJ, Rosengren LE, Verbeek MM. An enzyme immunoassay to quantify neurofilament light chain in cerebrospinal fluid. J Immunol Methods. 2005;296(1\u20132):179\u201385. https:\/\/doi.org\/10.1016\/j.jim.2004.11.015.","journal-title":"J Immunol Methods"},{"issue":"10","key":"455_CR343","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","volume":"14","author":"M Khalil","year":"2018","unstructured":"Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T, et al. Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol. 2018;14(10):577\u201389. https:\/\/doi.org\/10.1038\/s41582-018-0058-z.","journal-title":"Nat Rev Neurol"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00455-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00455-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00455-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T10:12:07Z","timestamp":1777284727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-026-00455-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":343,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["455"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00455-y","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"28 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}